{"title":"Breast Cancer Treatment Medications","description":"\u003cp\u003eBreast cancer treatment medications are used to target and destroy cancer cells in the breast tissue. Breast cancer treatments are often used in conjunction with surgery, radiation therapy, or chemotherapy to treat breast cancer. The specific treatment plan for breast cancer will depend on the type and stage of the cancer, as well as other factors such as the person's overall health and preferences. Some individuals may receive a combination of different treatments to effectively target their cancer. The goal of breast cancer treatment is to remove or destroy cancer cells in the breast, prevent the cancer from spreading, and improve the person’s overall quality of life..\u003c\/p\u003e","products":[{"product_id":"carboplatin-for-injection-450mg-45-ml","title":"Carboplatin Injection 450 mg \/ 45 mL Multi-dose Vial 45 mL, Preservative Free (RX)","description":"\u003ch1\u003eCarboplatin Injection 450 mg\/45 mL (Multi-dose vial, Preservative-Free)\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCarboplatin injection is a platinum-based chemotherapy (antineoplastic) drug. It is supplied as a sterile, preservative-free aqueous solution (10 mg carboplatin per mL) in a multi-dose vial. Each 45 mL vial contains 450 mg of carboplatin and 10 mg mannitol per mL (mannitol is an inert stabilizer). The solution is colorless to pale yellow and is formulated for intravenous use (no preservatives are added)\u003c\/span\u003e.\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eUses:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e Carboplatin is primarily used to treat ovarian cancer. It is indicated for the \u003cstrong\u003efirst-line (initial) treatment of advanced ovarian carcinoma\u003c\/strong\u003e in established combination with other chemotherapeutic agents (for example, carboplatin plus cyclophosphamide). It is also indicated for \u003cstrong\u003epalliative treatment of recurrent ovarian cancer\u003c\/strong\u003e in patients who have received prior chemotherapy (including those who relapsed after cisplatin therapy). (In practice, carboplatin is often given with other agents such as paclitaxel in gynecologic cancers.) Physicians may also use carboplatin off-label for other tumors (e.g. lung, head and neck, etc.), but the main approved use is ovarian carcinoma.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eHow to Use:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCarboplatin injection is given by slow intravenous infusion under healthcare supervision. The drug is typically infused over at least 15 minutes (often longer). Treatment cycles are usually repeated every 3–4 weeks, as determined by patient response and blood counts. The dose is personalized based on body surface area and kidney function, often calculated by the Calvert formula: dose (mg) = AUC × (GFR + 25), where AUC is the target area-under-curve. Carboplatin solution is typically further diluted in IV fluid (for example, 5% dextrose or normal saline) for infusion. Since no preservative is present, the prepared solution should be used within 8 hours of dilution and any unused portion discarded. (Unlike cisplatin, routine hydration or forced diuresis is generally not required during carboplatin administration \u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eCarboplatin vs Cisplatin\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism:\u003c\/strong\u003e Both carboplatin and cisplatin are platinum(II) coordination compounds that form DNA cross-links and inhibit DNA synthesis in cancer cells. Carboplatin is a derivative of cisplatin with similar action but different side-effect profiles.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eEfficacy:\u003c\/strong\u003e In ovarian cancer trials, carboplatin (with cyclophosphamide) achieved survival outcomes equivalent to cisplatin combinations. This means carboplatin is generally as effective as cisplatin for that indication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eToxicity differences:\u003c\/strong\u003e Carboplatin causes \u003cstrong\u003eless kidney (nephro-) and nerve (neuro-) toxicity\u003c\/strong\u003e than cisplatin. Cisplatin is highly nephrotoxic and emetogenic (causes severe nausea\/vomiting), whereas carboplatin has milder kidney effects and is better tolerated (causing less nausea). Conversely, carboplatin produces \u003cstrong\u003emore bone marrow suppression\u003c\/strong\u003e (especially thrombocytopenia) than cisplatin. For example, treatment with carboplatin often requires careful monitoring of blood counts and may cause significant anemia or bleeding risk, while cisplatin causes these effects to a lesser extent. Carboplatin’s peripheral neuropathy and hearing effects are also generally milder than those of cisplatin.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHematologic:\u003c\/strong\u003e The most common toxic effect is bone marrow suppression. Carboplatin frequently causes \u003cstrong\u003eanemia, leukopenia, and thrombocytopenia.\u003c\/strong\u003e This can lead to fatigue, infection or bleeding; blood counts must be checked before each cycle. (In fact, myelosuppression is dose-limiting with carboplatin.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal:\u003c\/strong\u003e Nausea and vomiting are fairly common (though typically less severe than with cisplatin). Diarrhea and loss of appetite (anorexia) may also occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNeurologic:\u003c\/strong\u003e Peripheral neuropathy (tingling, numbness or burning in the hands and feet) can occur. Notably, the incidence of serious neuropathy is relatively low, but risk increases with cumulative doses or prior cisplatin use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHair and General:\u003c\/strong\u003e Temporary hair loss (alopecia) is possible. Other common effects include fatigue and general weakness.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Allergic (hypersensitivity) reactions can occur, sometimes acutely during infusion. Symptoms range from mild rash to severe anaphylaxis (hives, difficulty breathing, swelling of face\/lips). Monitoring during infusion is important.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRenal\/Ototoxicity:\u003c\/strong\u003e Although less than with cisplatin, carboplatin can still affect kidneys and hearing. Mild kidney function changes are common (↑ BUN\/creatinine in some patients) and ~25% incidence of nephrotoxicity has been reported. Hearing impairment (tinnitus or hearing loss) occurs in a minority of patients (e.g. ~15%). Electrolyte disturbances (↓Mg, ↓K) may also occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOther:\u003c\/strong\u003e Carboplatin may also cause elevated liver enzymes, fever, and local injection-site reactions. Patients are usually given antiemetic and other supportive medications to manage side effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlways follow the prescribing information and your medical team’s instructions. This summary is not exhaustive; patients should consult their oncologist or pharmacist for personalized advice on carboplatin therapy.\u003c\/p\u003e\n\u003cp\u003eBrand: Pfizer Hospira\u003cbr\u003eSize: 450mg \/ 45 mL\u003cbr\u003eNDC: 61703-0339-50\u003cbr\u003eUPC: 361703-339508\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eBuy Carboplatin for Injection 450mg \/ 45 mL online at Mountainside Medical Equipment.\u003c\/p\u003e\n\u003c!-- Microdata markup added by Google Structured Data Markup Helper. --\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":12109892976712,"sku":"61703-0339-50","price":129.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Carboplatin_for_Injection_450mg_45_mL.jpg?v=1600352979"},{"product_id":"fareston-tablets-60-mg","title":"Fareston Tablets 60 mg","description":"\u003cp\u003eFareston Tablets (toremifene citrate) 60 mg used to treat patients with breast cancer. Fareston (toremifene citrate) is an estrogen agonist\/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.\u003c\/p\u003e\n\u003cp\u003eThe dosage of Fareston is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.\u003c\/p\u003e\n\u003cp\u003eBrand: Prostrakan Pharmaceutical Group\u003cbr\u003eSize: 30 Tablets\u003cbr\u003eStrength: 60 mg\u003cbr\u003eNDC: 42747-0327-30\u003cbr\u003eUPC: 342747327300\u003c\/p\u003e\n\u003cp\u003eBuy Fareston Tablets 60 mg to treat breast cancer online at Mountainside Medical Equipment.\u003c\/p\u003e","brand":"Prostrakan Pharmaceutical Group","offers":[{"title":"Default Title","offer_id":12227315400776,"sku":"42747-0327-30","price":1799.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Fareston-Tablets.jpg?v=1600361429"},{"product_id":"methotrexate-for-injection-250-mg-ml-vial-10ml","title":"Methotrexate Injection 250 mg\/mL Vial 10 mL (RX)","description":"\u003cp\u003eMethotrexate Injection is a trusted treatment for cancer, rheumatoid arthritis, and psoriasis. Methotrexate Injection delivers fast relief, reduces inflammation, and slows disease progression. Choose Methotrexate Injection for effective care. Methotrexate Injection supports your health with proven results. Related keywords: chemotherapy, rheumatoid arthritis treatment, psoriasis therapy, cancer medication.\u003c\/p\u003e\n\u003cp\u003eMethotrexate for Injection by Fresenius Kabi is a sterile, preservative-free solution formulated at 250 mg\/mL, supplied in a 10 mL single-use vial. This high-potency antineoplastic agent is designed for intravenous (IV), intramuscular (IM), intra-arterial (IA), or intrathecal (IT) administration by experienced healthcare professionals. Methotrexate is widely trusted for its role in the treatment of various cancers and certain autoimmune diseases.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWhat It Is Used For\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eMethotrexate for Injection is indicated for the management of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCertain neoplastic diseases, including \u003cstrong\u003eacute lymphoblastic leukemia (ALL)\u003c\/strong\u003e, breast cancer, lung cancer, head and neck cancer, and osteosarcoma\u003c\/li\u003e\n\u003cli\u003eSevere, recalcitrant, disabling \u003cstrong\u003epsoriasis\u003c\/strong\u003e unresponsive to other therapies\u003c\/li\u003e\n\u003cli\u003eRheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) when response to other treatments has been inadequate\u003c\/li\u003e\n\u003cli\u003eOther off-label autoimmune or inflammatory conditions as determined by your doctor\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDosage \u0026amp; CDC Guidelines\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003eDosage\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOncologic Uses\u003c\/strong\u003e: Doses typically range from 10 mg\/m² to 30 mg\/m² weekly, or as continuous infusion, depending on the disease protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePsoriasis \u0026amp; Rheumatoid Arthritis\u003c\/strong\u003e: Lower doses, generally 7.5 mg to 25 mg total per week, adjusted according to clinical response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlways individualize\u003c\/strong\u003e dosage based on indication, patient status, and physician guidance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eCDC Guidelines\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eThe Centers for Disease Control and Prevention (CDC) and other authorities recommend methotrexate be administered only by healthcare professionals familiar with its uses, toxicities, and safety precautions.\u003c\/li\u003e\n\u003cli\u003eRigorous monitoring (CBC, liver, and renal function tests) is required before and during therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDetails \u0026amp; Features\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 250 mg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVolume:\u003c\/strong\u003e 10 mL single-use vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Fresenius Kabi, renowned for its pharmaceutical quality and reliability\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile, preservative-free formulation\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEasy-to-read labeling and tamper-evident packaging\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSuitable for multiple routes of administration (IV, IM, IT, IA)\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eMethotrexate is an antimetabolite and antifolate drug. It inhibits dihydrofolate reductase, preventing the conversion of dihydrofolate to tetrahydrofolate. This blocks DNA synthesis, repair, and cellular replication, primarily targeting rapidly dividing cells, such as cancerous, psoriatic, and immune cells.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003e\u003cstrong\u003eTo be administered only by qualified healthcare providers in a clinical setting.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eInspect vial, ensuring solution is clear and free from particles.\u003c\/li\u003e\n\u003cli\u003eDosage and route are prescribed based on patient’s condition and treatment protocol.\u003c\/li\u003e\n\u003cli\u003eUse appropriate aseptic technique; avoid mixing with incompatible solutions.\u003c\/li\u003e\n\u003cli\u003eDispose of any unused portion; single-use only.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eALWAYS refer to the full prescribing information for detailed instructions.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethotrexate can cause serious, life-threatening side effects:\u003c\/strong\u003e liver toxicity, lung disease, bone marrow suppression, infections, and gastrointestinal toxicity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNot for use in pregnancy\u003c\/strong\u003e; causes fetal death or congenital anomalies. Women of childbearing age should use effective contraception during and after therapy.\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with liver, renal, or pre-existing bone marrow impairment.\u003c\/li\u003e\n\u003cli\u003eMay increase the risk of infections. Monitor closely.\u003c\/li\u003e\n\u003cli\u003eNot recommended for routine use in children unless specialized expertise is available.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eCommon side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea, vomiting, diarrhea\u003c\/li\u003e\n\u003cli\u003eStomatitis (mouth sores)\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003cli\u003eDizziness or headache\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects may involve:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere bone marrow suppression (anemia, bleeding, infections)\u003c\/li\u003e\n\u003cli\u003eHepatotoxicity (elevated liver enzymes, liver failure)\u003c\/li\u003e\n\u003cli\u003ePulmonary toxicity (pneumonitis)\u003c\/li\u003e\n\u003cli\u003eRenal impairment\u003c\/li\u003e\n\u003cli\u003ePhotosensitivity or rash\u003c\/li\u003e\n\u003cli\u003eAllergic reactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf any severe or unusual symptoms occur, seek immediate medical attention.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eConsult your healthcare provider for full prescribing information and before starting Methotrexate for Injection.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Fresenius Kabi","offers":[{"title":"Default Title","offer_id":12227713695816,"sku":"63323-0123-10","price":63.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Methotrexate-for-Injection-250-mg-Fresenius-63323-0123-10.jpg?v=1748609891"},{"product_id":"methotrexate-for-injection-25-mg-ml-vial-2ml","title":"Methotrexate Sodium Injection 50 mg Per 2 mL (25 mg\/mL) Multi-Dose Vials 2 mL x 5\/Pack (RX)","description":"\u003cp\u003eMethotrexate Sodium Injection is used to treat certain types of cancer, such as breast cancer, lung cancer, and leukemia, as well as autoimmune diseases like rheumatoid arthritis and severe psoriasis. It functions as an antimetabolite by interfering with DNA synthesis, thus inhibiting the growth of cancer cells and suppressing immune system activity. Administered intravenously or intramuscularly, Methotrexate requires careful dosing and monitoring to mitigate potential side effects, including liver toxicity and bone marrow suppression, ensuring safe and effective treatment.\u003c\/p\u003e\n\u003cp\u003ePfizer Injectables presents Methotrexate Sodium Injection, a well-established medication used in the treatment of certain types of cancer, severe psoriasis, and rheumatoid arthritis. Each multi-dose vial contains 25 mg\/mL of methotrexate sodium, featuring an effective formulation that meets a range of therapeutic needs. Packaged in a convenient set of five 2 mL vials, this product is ideal for healthcare professionals seeking a versatile, high-quality option for delivering precise doses over multiple administrations. Pfizer's commitment to safety and efficacy ensures that Methotrexate Sodium Injection remains a trusted choice in various medical settings.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Each 2 mL vial contains 25 mg\/mL of methotrexate sodium, a cornerstone in chemotherapy and immunosuppressive therapy.\u003cbr\u003e\u003cstrong\u003ePackaging: \u003c\/strong\u003eSupplied in packs containing five multi-dose vials, enabling effective storage and management for multiple dosing schedules.\u003cbr\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e Used as part of combination chemotherapy regimens, it is indicated for severe, recalcitrant, disabling psoriasis, rheumatoid arthritis, and certain types of cancer, including leukemia, breast cancer, and osteosarcoma.\u003cbr\u003e\u003cstrong\u003eAdministration: \u003c\/strong\u003eThe injectable form allows for precise dosing and rapid onset of action, suitable for both oncology and rheumatology therapeutic protocols.\u003cbr\u003e\u003cstrong\u003eManufacturing Excellence:\u003c\/strong\u003e Produced by Pfizer, guaranteeing stringent quality control and reliable therapeutic outcomes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMethotrexate interferes with DNA synthesis, repair, and cellular replication by inhibiting the enzyme dihydrofolate reductase. This enzyme is crucial for converting dihydrofolate to tetrahydrofolate, a carrier of one-carbon groups used in the synthesis of nucleotides thymidine and purine. As a result, methotrexate exerts cytotoxic effects on rapidly dividing cells, contributing to its effectiveness in cancer therapy and providing anti-inflammatory and immunosuppressive properties in rheumatoid arthritis and psoriasis treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression:\u003c\/strong\u003e Monitor blood counts frequently as methotrexate can cause marked bone marrow depression, leading to anemia, leukopenia, and thrombocytopenia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic and Renal Toxicity:\u003c\/strong\u003e Patients should undergo regular liver and kidney function tests due to the risk of severe hepatotoxicity and nephrotoxicity.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Nursing: \u003c\/strong\u003eContraindicated during pregnancy (Category X) and breastfeeding due to the potential for fetal harm and excretion in breast milk.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal Reactions:\u003c\/strong\u003e Could lead to serious complications such as ulcerative stomatitis, diarrhea, and gastrointestinal ulceration.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulmonary Toxicity:\u003c\/strong\u003e Watch for symptoms of pulmonary function impairment, which could indicate serious respiratory complications.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCommon side effects may include:\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea and vomiting\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eStomatitis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDizziness\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eSerious side effects requiring medical attention include:\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere skin reactions, possibly indicative of Stevens-Johnson syndrome or toxic epidermal necrolysis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSignificant changes in laboratory tests indicating liver or renal damage\u003cbr\u003e-ymptoms of infection due to immunosuppression, like unusual fatigue, cough, or increased temperature\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRespiratory distress symptoms such as persistent dry cough or difficulty breathing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMethotrexate Sodium Injection 25 mg\/mL by Pfizer Injectables is a vital medication in the therapeutic landscape, offering multifaceted benefits across oncology, dermatology, and rheumatology. With its robust mechanism of action backed by the reliability and quality assurance of Pfizer, healthcare providers can confidently incorporate this versatile agent into comprehensive treatment plans. Proper monitoring and adherence to safety protocols are essential to maximize its therapeutic potential and safeguard patient health.\u003cbr\u003e\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":12227713794120,"sku":"61703-0350-38","price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Methotrexate-Sodium-Injection-50-mg-Per-2-mL-Pfize-61703-0350-38r.jpg?v=1764766009"},{"product_id":"megestrol-acetate-20-mg-tablets-by-teva","title":"Megestrol Acetate 20 mg Tablets by Teva (RX)","description":"\u003cp\u003eMegestrol Acetate 20 mg tablets are a prescription medication used to treat certain types of cancer, specifically estrogen-sensitive cancers such as breast and endometrial cancer. It works by blocking the effects of estrogen in the body, slowing or stopping the growth and spread of cancer cells. Additionally, Megestrol Acetate 20 mg tablets may also be used to treat weight loss and poor appetite in patients with HIV\/AIDS or other medical conditions\u003c\/p\u003e\n\u003cp\u003eMegestrol Acetate 20 mg Tablets by Teva is a man-made chemical similar to the female hormone progesterone. Megestrol is used to treat loss of appetite and weight loss in people with acquired immunodeficiency syndrome (AIDS). Megestrol is also used in the treatment of advanced breast cancer and endometrial cancer.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eMegestrol Acetate also is used for palliative treatment of breast and endometrial carcinoma; treatment of anorexia, cachexia, or unexplained significant weight loss in patients with AIDS.\u003c\/p\u003e\n\u003cp\u003eMegestrol (me JES trole)\u003c\/p\u003e\n\u003cp\u003eBrand: Teva Pharmaceuticals\u003cbr\u003eSize: 100 Tablets\u003cbr\u003eStrength: 20 mg\u003cbr\u003eNDC: 00555-0606-02\u003cbr\u003eUPC: 305550606024\u003c\/p\u003e\n\u003cp\u003eBuy Megestrol Acetate (Megace) Tablets online at Mountainside Medical Equipment.\u003c\/p\u003e","brand":"Teva Pharmaceuticals","offers":[{"title":"Default Title","offer_id":12228146856008,"sku":"00555-0606-02","price":22.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Megestrol-Acetate-20-mg-Tablets-by-Teva.jpg?v=1600369494"},{"product_id":"pamidronate-disodium-for-injection-3mg-ml-single-dose-vial-10-ml","title":"Pamidronate Disodium Injection 3 mg\/mL Single Dose Vial 10 mL","description":"\u003cp\u003ePamidronate Disodium Injection is used primarily to treat hypercalcemia associated with malignancy, as well as to manage bone pain related to certain cancers such as multiple myeloma and metastatic breast cancer. It works as a bisphosphonate by inhibiting bone resorption, thereby reducing elevated blood calcium levels and bone pain. Additionally, it is used in the treatment of Paget's disease of bone. Administered intravenously, Pamidronate Disodium requires monitoring for renal function and other side effects by healthcare professionals.\u003c\/p\u003e\n\u003cp\u003ePfizer Injectables introduces Pamidronate Disodium Injection, an effective bisphosphonate therapy formulated at a concentration of 3 mg\/mL, presented in a convenient 10 mL single-dose vial. Designed for intravenous administration, this medication is highly beneficial in managing conditions associated with high bone turnover such as hypercalcemia of malignancy, Paget’s disease of bone, and osteolytic bone lesions in multiple myeloma and breast cancer patients. Produced with Pfizer’s commitment to quality and safety, this injectable solution provides a robust option for healthcare professionals seeking reliable and targeted bone health management.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Each 10 mL single-dose vial contains 3 mg\/mL of pamidronate disodium, a potent bisphosphonate compound aimed at regulating bone resorption.\u003cbr\u003e\u003cstrong\u003eMedical Indications:\u003c\/strong\u003e Primarily indicated for the treatment of hypercalcemia associated with malignancy (HCM), Paget’s disease, and osteolytic bone metastases of breast cancer and multiple myeloma.\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Provided in sterilized vials meant for single-use injection, ensuring ease of access and reliability during administration.\u003cbr\u003e\u003cstrong\u003eDosage Form:\u003c\/strong\u003e Designed for intravenous infusion, allowing precise delivery of the medication to the targeted area of effect.\u003cbr\u003e\u003cstrong\u003ePfizer Assurance:\u003c\/strong\u003e As a product of Pfizer, this injection meets high quality and ethical standards, incorporating advanced pharmaceutical technology into clinical therapy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePamidronate disodium acts by adhering to hydroxyapatite binding sites on bony surfaces, especially those undergoing active resorption. Through the inhibition of osteoclast activity (the cells responsible for bone degradation), pamidronate decreases bone turnover. This mechanism curtails the release of calcium from bones into the bloodstream, thereby managing elevated calcium levels due to cancer. Additionally, in conditions like Paget’s disease, it normalizes bone metabolism by reducing abnormal bone resorption and improving bone mineral density.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Impairment:\u003c\/strong\u003e Monitor renal function during treatment, as pamidronate can cause renal toxicity, particularly with high doses and rapid infusion rates.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHydration:\u003c\/strong\u003e Ensure patients are well hydrated before administration to minimize renal adverse effects.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypocalcemia:\u003c\/strong\u003e Use with caution in patients with pre-existing hypocalcemia. Such conditions should be corrected before commencing therapy.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy Category D: \u003c\/strong\u003ePamidronate is not recommended for use during pregnancy due to the potential for fetal harm.\u003cbr\u003e  \u003cbr\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCommon side effects may include:\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFever\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFatigue\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea and vomiting\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eBone pain\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eSerious side effects that demand immediate medical attention include:\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSymptoms of renal dysfunction (e.g., unexpected weight gain or swelling)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSevere skin reactions, which could signify allergies\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eJaw pain and swelling, potentially related to osteonecrosis of the jaw\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eElectrolyte imbalances beyond hypocalcemia, including magnesium and potassium deviations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePamidronate Disodium Injection 3 mg\/mL by Pfizer Injectables offers a comprehensive approach to managing conditions caused by rapid bone turnover and calcium metabolism imbalances. With its proven efficacy and safety profile upheld by Pfizer’s high manufacturing standards, healthcare professionals can apply this therapy confidently to improve patient outcomes in those with malignancy-related calcium disorders and other bone-related illnesses. Always consult with a healthcare professional to tailor the therapy to individual patient needs and conditions.\u003cbr\u003e\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":39641289228360,"sku":"61703-0324-18","price":29.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Pamidronate-Disodium-for-Injection-3mg-mL-Single-Dose-Vial-10-mL.jpg?v=1666889558"},{"product_id":"herceptin-hylecta-trastuzumab-and-hyaluronidase-oysk-5-ml-rx","title":"Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL (RX) **Refrigeration Required","description":"\u003cp\u003eExperience effective breast cancer treatment with Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL), enhancing patient care.\u003c\/p\u003e\n\u003cp\u003eHerceptin Hylecta is a prescription medication used to treat certain types of breast cancer that are HER2-positive. It contains two active ingredients, trastuzumab and Hyaluronidase-Oysk, which work together to block the activity of HER2 proteins, slowing the growth and spread of cancer cells. The medication is administered as an injection under the skin every 3 weeks and the 5 mL refers to the amount of solution in each individual dose.\u003c\/p\u003e\n\u003cp\u003eHerceptin Hylecta is a medication for the treatment of certain types of breast cancer. It is a combination of the drug trastuzumab and the enzyme hyaluronidase. \u003cbr\u003e\u003cbr\u003eTrastuzumab is a monoclonal antibody that works by binding to a protein called HER2, which is present in large amounts in some breast cancer cells. By binding to HER2, trastuzumab can slow down or stop the growth and spread of these cancer cells.\u003cbr\u003e\u003cbr\u003eHyaluronidase is an enzyme that helps to break down a substance called hyaluronic acid, which is found in the connective tissues in the body. Hyaluronidase helps to create channels in these tissues, allowing medications like trastuzumab to be more easily absorbed into the bloodstream.\u003cbr\u003e\u003cbr\u003eTogether, trastuzumab and hyaluronidase work to fight against HER2-positive breast cancer by slowing down tumor growth and potentially shrinking it.\u003cbr\u003e\u003cbr\u003eHerceptin Hylecta is administered as an injection under the skin every 3 weeks. It may be used alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy.\u003c\/p\u003e","brand":"Genentech USA","offers":[{"title":"Default Title","offer_id":40143942516808,"sku":"50242-0077-01","price":6495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Herceptin-Hylecta-_trastuzumab-and-Hyaluronidase-Oysk-Injection-5-mL.jpg?v=1710763216"},{"product_id":"herceptin-trastuzumab-injection-150-mg-cancer-treatment-medicine-rx-refrigeration-required","title":"Herceptin Trastuzumab Injection 150 mg (RX) * Refrigeration Required *","description":"\u003cp\u003eHerceptin Trastuzumab Injection 150 mg is a type of biologic cancer treatment medicine that is used to treat certain types of breast cancer, stomach cancer, and esophageal cancer. It contains the active ingredient trastuzumab, which works by targeting and blocking a protein called HER2 on the surface of cancer cells. This protein helps these cells grow and divide, and by blocking it, Herceptin can slow or stop the growth of cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003eThis item is Special Order.                                                                                                        -  Ships in 2-3 Business Days, Next Day Air, Signature Required.                                          -  Order cannot be cancelled once placed.\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eHerceptin Trastuzumab Injection 150 mg is a cancer treatment medicine that works by targeting and blocking the activity of a specific protein called HER2. This protein is found in high levels on the surface of some cancer cells, particularly in breast and stomach cancers.\u003cbr\u003e\u003cbr\u003eBy blocking HER2, Herceptin Trastuzumab reduces the growth and spread of cancer cells. It does this by slowing down the division of cancer cells, killing them, or stopping them from multiplying and spreading to other parts of the body.\u003cbr\u003e\u003cbr\u003eHerceptin Trastuzumab is typically used in combination with other cancer treatments, such as chemotherapy and radiation therapy. It may also be used alone for certain types of cancer.\u003cbr\u003e\u003cbr\u003eOverall, Herceptin Trastuzumab helps to slow down the progression of cancer and improve outcomes for patients with HER2-positive cancers.\u003c\/p\u003e","brand":"Genentech USA","offers":[{"title":"Default Title","offer_id":40143942647880,"sku":"50242-0132-01","price":2385.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Herceptin-Trastuzumab-Injection-150-mg-Vial.jpg?v=1710764147"},{"product_id":"ogivri-trastuzumab-injection-150-mg","title":"Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX)","description":"\u003cp\u003eOgivri Trastuzumab-Dkst Injection 150 mg is a medication used in the treatment of certain types of breast cancer and stomach cancer. It contains the active ingredient trastuzumab and belongs to a class of drugs known as monoclonal antibodies. It works by specifically targeting and blocking the action of a protein called HER2, which is overexpressed in some types of cancer cells. By blocking HER2, Ogivri helps to slow down or stop the growth and spread of cancer cells.\u003c\/p\u003e\n\u003cp\u003eOgivri Trastuzumab-Dkst Injection 150 mg is a type of cancer medication called a monoclonal antibody. It targets a protein called human epidermal growth factor receptor 2 (HER2) which is found on the surface of some cancer cells. By binding to HER2, Ogivri helps to slow down or stop the growth and spread of HER2-positive cancer cells.\u003cbr\u003e\u003cbr\u003eSpecifically, Ogivri works by blocking the action of HER2, which is involved in stimulating cell growth and division. This helps to slow down the growth of cancer cells and can potentially lead to their death. In addition, Ogivri also stimulates an immune response against the cancer cells, further aiding in their destruction.\u003cbr\u003e\u003cbr\u003eOverall, by targeting HER2 and stimulating the immune system, Ogivri can help to treat certain types of breast and stomach cancers that overexpress this protein.\u003c\/p\u003e","brand":"Biocon Biologics","offers":[{"title":"Default Title","offer_id":40143946973256,"sku":"83257-0001-11","price":1295.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ogivri-Trastuzumab-Dkst-Injection-150-mg-Vial.jpg?v=1710765239"},{"product_id":"ontruzant-trastuzumab-dttb-injection-150-mg-cancer-medicine-refrigeration-required-rxrx","title":"Ontruzant Trastuzumab-Dttb Injection 150 mg Cancer Medicine **Refrigeration Required** (RX)","description":"\u003cp\u003eOntruzant Trastuzumab-Dttb Injection 150 mg is a cancer medication used to treat certain types of breast, stomach, and gastroesophageal junction cancers that overexpress the HER2 protein. This injection contains the active ingredient trastuzumab-dttb and belongs to a class of drugs known as monoclonal antibodies. It works by binding to the HER2 protein on cancer cells and blocking their growth and division, ultimately leading to cell death. Ontruzant is biosimilar to the brand-name medication Herceptin, meaning it has been shown to be highly similar in effectiveness and safety profile. It is administered intravenously (into a vein) by a healthcare provider.\u003c\/p\u003e\n\u003cp\u003eOntruzant Trastuzumab-Dttb belongs to a class of medications known as monoclonal antibodies. It works by binding to a specific protein called HER2 (human epidermal growth factor receptor 2). HER2 is found in high levels on the surface of some cancer cells, including breast and gastric cancers. This protein helps cancer cells grow and spread.\u003cbr\u003e\u003cbr\u003eBy blocking the function of HER2, Ontruzant Trastuzumab-Dttb slows down the growth and spread of cancer cells. It also stimulates the body's immune system to attack and destroy the cancer cells.\u003cbr\u003e\u003cbr\u003eIn addition, Ontruzant Trastuzumab-Dttb may work with other chemotherapy medications to further inhibit the growth of cancer cells.\u003cbr\u003e\u003cbr\u003eOverall, Ontruzant Trastuzumab-Dttb helps in treating cancers that overexpress HER2 protein, such as breast and gastric cancers.\u003c\/p\u003e","brand":"Organon Biosimilar","offers":[{"title":"Default Title","offer_id":40143947202632,"sku":"78206-0147-01","price":1795.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ontruzant--78206-0147-01-Trastuzumab-Dttb-Injection.jpg?v=1710767106"},{"product_id":"ontruzant-trastuzumab-dttb-injection-420-mg-cancer-medicine-refrigeration-required-rx","title":"Ontruzant Trastuzumab-Dttb Injection 420 mg **Refrigeration Required** (RX)","description":"\u003cp\u003eOntruzant Trastuzumab-Dttb Injection 420 mg is a cancer medicine used to treat breast cancer, stomach cancer, and other types of cancer that overexpress the HER2 protein. It belongs to a class of drugs called monoclonal antibodies, which work by targeting and inhibiting the activity of HER2 receptors on cancer cells. By blocking these receptors, Ontruzant helps to slow or stop the growth and spread of cancer cells in the body. This medication is administered through injection by a healthcare professional.\u003c\/p\u003e\n\u003cp\u003eOntruzant Trastuzumab-Dttb is a monoclonal antibody that works by binding to a protein called HER2, which is found on the surface of some cancer cells. When this antibody binds to HER2, it blocks the growth and spread of cancer cells. This helps to slow down or stop the growth of cancer and can also help the body's immune system to recognize and attack cancer cells. It is commonly used to treat breast cancer that overexpresses the HER2 protein.\u003c\/p\u003e\n\u003cp\u003eBrand: Organon Biosimilar\u003cbr\u003eStrength: 420 mg\u003cbr\u003eNDC: 78206-0148-01\u003cbr\u003eType: Powder Vial\u003c\/p\u003e","brand":"Organon Biosimilar","offers":[{"title":"Default Title","offer_id":40143947464776,"sku":"78206-0148-01","price":5150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ontruzant-Trastuzumab-Dttb-Injection-420-mg-Cancer-Medicine.jpg?v=1710767571"},{"product_id":"temsirolimus-cancer-treatment-kit","title":"Temsirolimus Injection Kit 25 mg (RX) **Refrigerated","description":"\u003cp\u003eA Temsirolimus kit is a medical product used in the treatment of certain types of cancer. It contains the drug temsirolimus, which belongs to a class of medications called mTOR inhibitors. Temsirolimus works to block the activity of a protein called mTOR, which helps cancer cells grow and divide. By inhibiting mTOR, temsirolimus helps to slow or stop the growth and spread of cancer cells, ultimately preventing the progression of the disease. The kit may also contain other components such as diluents and syringes for administration of the medication.\u003c\/p\u003e\n\u003cp\u003eTemsirolimus cancer treatment kit is primarily used to treat renal cell carcinoma (kidney cancer) and mantle cell lymphoma (a type of blood cancer). It may also be used to treat other types of cancer, such as breast cancer and non-small cell lung cancer, in certain cases. However, its effectiveness in treating these other types of cancer is still being studied.\u003c\/p\u003e\n\u003cp\u003eTemsirolimus is an anti-cancer medication that belongs to a class of drugs called mTOR inhibitors. It is used in the treatment of certain types of cancers, such as advanced renal cell carcinoma (a type of kidney cancer), mantle cell lymphoma (a type of non-Hodgkin's lymphoma), and some forms of non-small cell lung cancer.\u003cbr\u003e\u003cbr\u003eThe Temsirolimus Cancer Treatment Kit includes an injection vial of temsirolimus, a powder that is mixed with a diluent solution to create a liquid for injection. The kit also contains syringes and needles for administration.\u003cbr\u003e\u003cbr\u003eTemsirolimus works by inhibiting a protein called the mammalian target of rapamycin (mTOR), which is involved in cell growth and division. By blocking mTOR, temsirolimus slows or stops the growth of cancer cells.\u003cbr\u003e\u003cbr\u003eWhen injected into the body, temsirolimus is distributed throughout the bloodstream and targets the mTOR protein in cancer cells. This inhibits the growth and division of these cells, ultimately leading to their death. Temsirolimus also has a dual effect on the immune system, boosting its anti-cancer activities and interfering with the growth of new blood vessels that tumors depend on for growth.\u003cbr\u003e\u003cbr\u003eThe Temsirolimus Cancer Treatment Kit is typically prescribed by a doctor and administered by a healthcare professional. The exact dosage and treatment schedule will depend on the type of cancer being treated and the individual's medical history. Common side effects of temsirolimus may include nausea, vomiting, fatigue, and decreased appetite. It is important to discuss any potential side effects with a doctor.\u003cbr\u003e\u003c\/p\u003e","brand":"Almaject","offers":[{"title":"Default Title","offer_id":40226637938760,"sku":"72611-0785-02","price":1895.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Temsirolimus-Cancer-Treatment-Kit.jpg?v=1713535189"},{"product_id":"vinorelbine-tartrate-injection-10-mg-ml-single-dose-vial-preservative-free-1-ml-rx","title":"Vinorelbine Tartrate Injection 10 mg \/ mL Single-Dose Vial, Preservative Free 1 mL Rx) *Refrigerated Item*","description":"\u003cp\u003eVinorelbine Tartrate Injection is a medication used to treat certain types of cancer, including lung cancer and breast cancer. It is a chemotherapy drug that works by stopping the growth and spread of cancer cells in the body. The 10 mg\/mL single-dose vial is a specific form and strength of this medication, meaning each mL of the solution contains 10 mg of vinorelbine tartrate. It is also preservative-free, meaning it does not contain any additional chemicals or substances that could potentially cause an allergic reaction or other adverse effects. The vial is intended for one-time use only, with the entire contents being administered to the patient in one dose. It is important to follow the specific dosing and administration instructions provided by a healthcare professional when using this medication.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e* Refrigerated Item * Must ship Next Day Air *\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVinorelbine tartrate is an anticancer medication that belongs to a class of drugs known as vinca alkaloids. It is used to treat certain types of cancer, such as non-small cell lung cancer and breast cancer. It works by preventing the growth and spread of cancer cells in the body. Vinorelbine tartrate may be given alone or in combination with other medications as part of a chemotherapy regimen. It is typically given by injection into a vein. Common side effects include nausea, vomiting,\u003c\/p\u003e","brand":"Sagent Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40279544135752,"sku":"25021-0204-01","price":48.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Vinorelbine-Tartrate-Injection-10-mg.jpg?v=1716314986"},{"product_id":"gemcitabine-injection-200gm-single-dose-vial-5-26-ml-rx","title":"Gemcitabine injection 200 mg Single Dose Vial 5.26 mL (RX)","description":"\u003cp\u003eGemcitabine injection is a medication used to treat certain types of cancers, including breast, lung, and pancreatic cancer. It belongs to a class of drugs known as antimetabolites, which work by disrupting the growth and division of cancer cells. Gemcitabine is typically given intravenously (through a vein) by a healthcare professional. It may be used alone or in combination with other chemotherapy drugs. \u003c\/p\u003e\n\u003cp\u003eGemcitabine injection 200mg Single Dose Vial 5.26 mL is a prescription medication manufactured by Meitheal Pharmaceuticals. It contains the active ingredient gemcitabine, which belongs to a class of drugs known as antineoplastic agents. It is used to treat certain types of cancer, including breast, lung, and pancreatic cancer. The vial contains 200gm (grams) of gemcitabine in a single dose, which is equivalent to 5.26 mL (milliliters) of solution. The vial is intended for single use only and should be administered by a healthcare professional. Gemcitabine injection works by slowing or stopping the growth of cancer cells. It may also be used in combination with other medications as directed by a doctor.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits for Gemcitabine injection 200mg?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e1) Treatment of Cancer: Gemcitabine injection is primarily used in the treatment of various types of cancer, including non-small cell lung cancer, breast cancer, pancreatic cancer, and bladder cancer.\u003c\/p\u003e\n\u003cp\u003e2) Improved survival rates: Studies have shown that gemcitabine injection can significantly improve the survival rates of cancer patients, especially when used in combination with other chemotherapy drugs.\u003c\/p\u003e\n\u003cp\u003e3) Quick-acting: Gemcitabine injection has a quick onset of action, with effects seen within a few days after administration. This is important for patients who require immediate treatment for their condition.\u003c\/p\u003e\n\u003cp\u003e4) Well-tolerated: Gemcitabine injection is generally well-tolerated by patients, with minimal side effects such as nausea, vomiting, and hair loss. This makes it a suitable option for patients who may not be able to tolerate other types of chemotherapy drugs.\u003c\/p\u003e\n\u003cp\u003e5) Single Dose Convenience: Gemcitabine injection is available in a single-dose vial, making it easy for healthcare providers to administer the exact amount of medication needed without any leftover wastage.\u003c\/p\u003e\n\u003cp\u003e6) Cost-effective: As compared to other chemotherapy drugs, gemcitabine injection is relatively cost-effective, making it a viable option for patients who may have financial constraints.\u003c\/p\u003e\n\u003cp\u003e7) Can be used in combination with other drugs: Gemcitabine injection can be used in combination with other chemotherapy drugs to create a more effective treatment plan for cancer patients. \u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293412667464,"sku":"71288-0117-06","price":12.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gemcitabine-injection-200gm-Single-Dose-Vial-5.26-mL.jpg?v=1716907671"},{"product_id":"gemcitabine-injection-200mg-single-dose-glass-vial-10-ml-rx","title":"Gemcitabine injection 200 mg Single Dose Glass Vial 10 mL (RX)","description":"\u003cp\u003eGemcitabine injection is a medication used to treat certain types of cancers, including breast, lung, and pancreatic cancer. It belongs to a class of drugs known as antimetabolites, which work by disrupting the growth and division of cancer cells. Gemcitabine is typically given intravenously (through a vein) by a healthcare professional. It may be used alone or in combination with other chemotherapy drugs. \u003c\/p\u003e\n\u003cp\u003eGemcitabine injection 200mg Single Dose Glass Vial 10 mL is a prescription medication used for the treatment of various types of cancer, including breast, lung, pancreatic, ovarian, and bladder cancer. It contains 200mg of gemcitabine in a single-dose glass vial of 10 mL. Gemcitabine is a chemotherapy drug that works by interfering with the growth and spread of cancer cells in the body. It is typically administered through a vein by a healthcare professional. This specific dose and packaging may vary depending on the individual's medical condition and treatment plan.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat are Antimetabolites?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntimetabolites are molecules that resemble naturally occurring metabolites and disrupt metabolic processes within cells. They can act as competitive inhibitors of key enzymes involved in cellular metabolism, effectively blocking the normal function of these enzymes. This disruption can lead to the inhibition of cell growth and replication, making antimetabolites useful as chemotherapy agents for treating cancer. Some examples of antimetabolites include methotrexate, 5-fluorouracil, and gemcitabine.\u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293413978184,"sku":"71288-0113-10","price":12.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gemcitabine-injection-200mg-Single-Dose-Glass-Vial-10-mL.jpg?v=1716908411"},{"product_id":"gemcitabine-injection-1-gram-single-dose-glass-vial-50-ml-rx","title":"Gemcitabine injection 1 gram Single Dose Glass Vial 50 mL (RX)","description":"\u003cp\u003eGemcitabine injection is a medication used to treat certain types of cancers, including breast, lung, and pancreatic cancer. It belongs to a class of drugs known as antimetabolites, which work by disrupting the growth and division of cancer cells. Gemcitabine is typically given intravenously (through a vein) by a healthcare professional. It may be used alone or in combination with other chemotherapy drugs. \u003c\/p\u003e\n\u003cp\u003eGemcitabine injection is a chemotherapy medication used to treat certain types of cancer, such as lung, breast, ovarian, and pancreatic cancer. It is available in a single dose glass vial containing 1 gram (1000 milligrams) of the medication in 50 mL of liquid. This form of the medication is administered intravenously (through a vein) by a healthcare professional. It works by stopping the growth and spread of cancer cells in the body. \u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGemcitabine injection is a chemotherapy drug that works by interfering with the growth and reproduction of cancer cells. It is a type of antimetabolite that disrupts the synthesis of nucleic acids, which are essential for cellular division and replication. As a result, cancer cells are unable to grow and spread, ultimately leading to their death. Gemcitabine is commonly used to treat various types of cancer, including pancreatic, lung, breast, and ovarian cancer. It may also be used in combination with other chemotherapy drugs to improve its effectiveness.\u003c\/p\u003e","brand":"Meitheal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293462376520,"sku":"71288-0114-50","price":59.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gemcitabine-injection-1-gram-Single-Dose-Glass-Vial-50-mL.jpg?v=1716911123"},{"product_id":"dexamethasone-sodium-phosphate-4-mg-for-injection-single-dose-vials-1-ml-x-25-pack-rx","title":"Dexamethasone Sodium Phosphate 4 mg Injection Single Dose Vials 1 mL x 25\/Pack (Rx)","description":"\u003ch4\u003e\u003cstrong\u003e#1 Hospital-Grade Steroid Injection for Inflammation, Allergic Reactions \u0026amp; Severe Conditions\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003eDexamethasone Sodium Phosphate Injection 4 mg\/mL by Mylan Institutional is the top choice for medical professionals requiring fast-acting, high-potency corticosteroid therapy in acute and emergency care settings. With 25 sterile, single-dose 1 mL vials per pack, this universal corticosteroid solution delivers unparalleled efficacy for treating \u003cstrong\u003esevere inflammation\u003c\/strong\u003e, \u003cstrong\u003eallergic reactions\u003c\/strong\u003e, \u003cstrong\u003eadrenal insufficiency\u003c\/strong\u003e, \u003cstrong\u003eshock\u003c\/strong\u003e, \u003cstrong\u003ecerebral edema\u003c\/strong\u003e, and a wide range of autoimmune and oncological indications.\u003c\/p\u003e\n\u003ch2\u003eWhat Is Dexamethasone Sodium Phosphate Injection Used For?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSevere Inflammatory Conditions\u003c\/strong\u003e (rheumatoid arthritis, lupus, inflammatory bowel diseases)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcute allergic\/anaphylactic reactions\u003c\/strong\u003e refractory to standard therapy\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdrenal insufficiency\/crisis\u003c\/strong\u003e and stress dosing in steroid-dependent patients\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAsthma \u0026amp; COPD exacerbations\u003c\/strong\u003e (when rapid control is needed)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCerebral edema\u003c\/strong\u003e associated with brain tumors or trauma\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer\/oncology regimens\u003c\/strong\u003e (antiemetic, tumor edema, part of chemotherapy protocols)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShock \u0026amp; septic shock\u003c\/strong\u003e (as adjunct therapy)\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSevere dermatologic, hematologic, or ophthalmic conditions\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePreoperative, intraoperative, and postoperative anti-inflammatory therapy\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eProduct Features \u0026amp; Clinical Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Potency 4 mg\/mL Steroid:\u003c\/strong\u003e Provides immediate, broad-spectrum anti-inflammatory and immunosuppressant effects\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile, Preservative-Free, Single Dose Vials:\u003c\/strong\u003e Individual 1 mL vials ensure maximum sterility and dosage accuracy, minimizing contamination risk and waste\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Administration:\u003c\/strong\u003e For intravenous (IV), intramuscular (IM), and intra-articular administration when oral dosing is not possible or rapid action is required\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHospital, Emergency \u0026amp; Oncology Use:\u003c\/strong\u003e Trusted for rapid intervention in shock, acute allergic reactions, cerebral edema, severe asthma, rheumatoid\/autoimmune flares, oncology protocols, and adrenal insufficiency\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDependable Mylan Quality:\u003c\/strong\u003e Manufactured by Mylan Institutional under stringent FDA and USP standards, batch tested for safety, potency, and consistency\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient 25\/Pack:\u003c\/strong\u003e Perfect for hospitals, emergency departments, oncology suites, surgery centers, and urgent care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHow to Use (Professional Use Only)\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFor IV, IM, or intra-articular injection only.\u003c\/strong\u003e Not for subcutaneous use.\u003c\/li\u003e\n\u003cli\u003eDosage individualized by indication, patient weight\/age, severity, and response.\u003c\/li\u003e\n\u003cli\u003eAdminister under sterile conditions in a healthcare setting, following hospital or institutional protocols.\u003c\/li\u003e\n\u003cli\u003eFollow all package insert instructions and monitor patient closely for efficacy and side effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cp\u003eWhile \u003cstrong\u003edexamethasone sodium phosphate injection\u003c\/strong\u003e is highly effective, it carries potential risks. Most common:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFluid retention, swelling, or increased blood pressure\u003c\/li\u003e\n\u003cli\u003eHyperglycemia (elevated blood sugar)\u003c\/li\u003e\n\u003cli\u003eInsomnia, mood changes, agitation\u003c\/li\u003e\n\u003cli\u003eIncreased risk of infection, delayed wound healing\u003c\/li\u003e\n\u003cli\u003eStomach upset, ulcer risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious\/Rare:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere allergic reaction (anaphylaxis)\u003c\/li\u003e\n\u003cli\u003eHeart rhythm disturbances\u003c\/li\u003e\n\u003cli\u003eGI bleeding, perforation\u003c\/li\u003e\n\u003cli\u003eAdrenal suppression\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eAlways monitor patients closely. Adjust dose or discontinue if severe side effects occur.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eWarnings \u0026amp; Precautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eFor use by trained healthcare professionals only\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eUse lowest effective dose for shortest possible duration\u003c\/li\u003e\n\u003cli\u003eContraindicated in systemic fungal infections, untreated infections, and those with known hypersensitivity to dexamethasone or excipients\u003c\/li\u003e\n\u003cli\u003eMonitor for psychiatric changes, hyperglycemia, fluid\/electrolyte imbalance, GI symptoms, and secondary infections\u003c\/li\u003e\n\u003cli\u003eUse with caution in pregnancy, breastfeeding, pediatrics, or those with renal\/hepatic impairment, diabetes, peptic ulcer, or hypertension\u003c\/li\u003e\n\u003cli\u003eTaper dosing if used longer than a few days to avoid adrenal crisis\u003c\/li\u003e\n\u003cli\u003eNot for routine use in mild conditions—reserved for severe or refractory cases\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhy Choose Dexamethasone Sodium Phosphate by Mylan Institutional?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eTrusted worldwide by physicians, hospitals, and emergency teams\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRapid, reliable anti-inflammatory action\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile single-dose vials for exact dosing and top infection control\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMeets all FDA and institutional standards\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNDC: 67457-0423-12 | UPC: 367457423128 | Mylan Product #: 042312\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e25 vials per pack = efficiency for high-volume healthcare environments\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eEnsure Immediate, Effective Intervention—Order Dexamethasone Sodium Phosphate Injection 4 mg\/mL from Mylan Institutional Today!\u003c\/h3\u003e\n\u003cp\u003eUnmatched reliability for \u003cstrong\u003ehospital emergencies, rapid allergy and anaphylaxis management, acute inflammation, oncological support, and adrenal crisis intervention\u003c\/strong\u003e—your essential hospital steroid solution.\u003c\/p\u003e","brand":"Mylan Institutional","offers":[{"title":"Default Title","offer_id":40350553800776,"sku":"67457-0423-12","price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Dexamethasone-Sodium-Phosphate-4-mg-Injection.jpg?v=1767634324"},{"product_id":"presnisone-tablets-5-mg-by-cadista-100-count-rx","title":"Prednisone Tablets 5 mg by Cadista 100 Count (RX)","description":"\u003cp\u003ePrednisone tablets 5 mg are a type of glucocorticoid medication that is used to treat a variety of conditions, including inflammation, allergies, and autoimmune disorders. It works by reducing the body's immune response to certain stimuli, thereby reducing inflammation and reducing the symptoms associated with these conditions. Prednisone tablets are available in different strengths, with 5 mg being a lower dose version. They are usually taken orally and can be used for short-term or long-term treatment, depending on the condition being treated.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action for Prednisone Tablets 5 mg:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePrednisone tablets 5 mg contain the active ingredient prednisone, which is a synthetic corticosteroid. The mechanism of action for prednisone is complex and involves multiple pathways in the body.\u003c\/p\u003e\n\u003cp\u003eWhen taken orally, the tablet is absorbed into the bloodstream and distributed throughout the body. In the liver, prednisone is converted into its active form, prednisolone. Prednisolone then enters the cells of various tissues and binds to glucocorticoid receptors, which are present in most cells of the body.\u003c\/p\u003e\n\u003cp\u003eOnce bound to the glucocorticoid receptors, prednisolone affects the expression of genes, leading to changes in the production of proteins. This results in a wide range of effects in the body, including:\u003c\/p\u003e\n\u003cp\u003e1. Anti-inflammatory effects: Prednisone suppresses the production of cytokines and mediators of inflammation, which are responsible for causing the symptoms of inflammation such as redness, swelling, and pain.\u003c\/p\u003e\n\u003cp\u003e2. Immunosuppressive effects: Prednisone inhibits the function of immune cells, including white blood cells, which play a key role in the body's defense against infection and disease.\u003c\/p\u003e\n\u003cp\u003e3. Anti-allergic effects: Prednisone reduces the production of immune chemicals that trigger allergic reactions, such as histamine, leading to a decrease in allergy symptoms.\u003c\/p\u003e\n\u003cp\u003e4. Metabolic effects: Prednisone can cause an increase in blood sugar levels, as well as changes in the metabolism of protein, fat, and carbohydrates.\u003c\/p\u003e\n\u003cp\u003eOverall, the mechanism of action of prednisone tablets 5 mg is to decrease inflammation, suppress the immune system, and provide relief from a variety of diseases and conditions.\u003cbr\u003e\u003c\/p\u003e","brand":"Cadista Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40362900619336,"sku":"59746-0172-06","price":34.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Presnisone-Tablets-5-mg-by-Cadista-NDC-59746-0172-06.jpg?v=1721828256"},{"product_id":"paclitaxel-protein-bound-particles-for-injectable-suspension-albumin-bound","title":"Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) Powder Vial (RX)","description":"\u003cp\u003ePaclitaxel protein-bound particles for injectable suspension is a medication used to treat various types of cancer, including breast, lung, and pancreatic cancer. It is marketed under the brand name Abraxane. This medication is a type of chemotherapy that belongs to the group of drugs known as taxanes. It works by interfering with the growth and spread of cancer cells in the body. Unlike traditional paclitaxel, paclitaxel protein-bound particles are bonded to albumin, a protein commonly found in the body, which may make it more effective and less toxic. It is administered through injection into the bloodstream by a healthcare professional.\u003c\/p\u003e\n\u003cp\u003ePaclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) works by inhibiting the growth and spread of cancer cells. It is a type of chemotherapy drug known as a taxane, which works by interfering with the normal function of microtubules, a structure within cells that helps them divide and grow.\u003c\/p\u003e\n\u003cp\u003eIn order for cancer cells to continue dividing and growing, they need to form new microtubules. Paclitaxel works by binding to microtubules and preventing them from functioning properly. This leads to an accumulation of microtubules in the cell, which disrupts normal cellular processes and ultimately results in cell death.\u003c\/p\u003e\n\u003cp\u003eThe protein-bound particles in this medication help to improve the delivery and effectiveness of the paclitaxel. They allow the drug to stay in the body for a longer period of time and be more specifically targeted to cancer cells, reducing the side effects on healthy cells.\u003c\/p\u003e\n\u003cp\u003e Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) helps to slow or stop the growth of cancer cells, preventing the spread of the disease and improving the chances for successful treatment.\u003c\/p\u003e","brand":"American Regent","offers":[{"title":"Default Title","offer_id":40370085462088,"sku":"00517-4300-01","price":3199.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/PaclitaxelProtein-BoundInjection.jpg?v=1722988758"},{"product_id":"cisplatin-injection-100-mg-100-ml-1-mg-ml-preservative-free-multiple-use-vial-100-ml-rx","title":"Cisplatin Injection 100 mg\/100 mL (1 mg\/mL) Preservative Free Multiple Use Vial 100 mL (RX)","description":"\u003cp\u003eCisplatin Injection 100 mg\/100 mL (1 mg\/mL) is a prescription medication that is commonly used as a chemotherapy drug. It is a colorless liquid that is administered into the vein by a healthcare professional. Each vial contains 100 mg of cisplatin in 100 mL of solution, resulting in a concentration of 1 mg\/mL. The vial does not contain any preservatives and can be used for multiple doses, as directed by a doctor. This medication works by damaging the DNA of cancer cells, which helps to slow or stop their growth and reproduction. It may be used to treat a variety of cancers, such as ovarian cancer, lung cancer, or testicular cancer. It is important to follow all dosage and safety instructions provided by a doctor while using this medication.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does it Work?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCisplatin Injection 100 mg\/100 mL (1 mg\/mL) is a chemotherapy medication used to treat various types of cancer, such as lung, ovarian, bladder, and testicular cancer. It works by damaging the DNA of cancer cells, which leads to their death.\u003c\/p\u003e\n\u003cp\u003eCisplatin belongs to a class of medications called platinum-based drugs. It contains the active ingredient cisplatin, which is a platinum compound. When cisplatin enters the body, it attaches to and damages the DNA of cancer cells, preventing them from reproducing and dividing. This ultimately leads to the death of the cancer cells.\u003c\/p\u003e\n\u003cp\u003eCisplatin also interferes with the ability of cancer cells to repair damages to their DNA. This further contributes to the destruction of cancer cells. Additionally, cisplatin can create free radicals, which cause oxidative stress and damage to the cancer cells.\u003c\/p\u003e\n\u003cp\u003eIn addition to directly killing cancer cells, cisplatin also works by preventing the formation of new blood vessels that supply nutrients to the tumors. This process is known as angiogenesis and it plays an important role in the growth and spread of tumors. By inhibiting angiogenesis, cisplatin can slow down the growth and spread of cancer cells.\u003c\/p\u003e\n\u003cp\u003eOverall, Cisplatin Injection 100 mg\/100 mL (1 mg\/mL) is a powerful medication that works by stopping the growth and spread of cancer cells. It is often used in combination with other chemotherapy drugs to increase its effectiveness.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Accord Healthcare","offers":[{"title":"Default Title","offer_id":40373326315592,"sku":"16729-0288-38","price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cisplatin-Injection-100-mg-Multiple-Use-Vial-nDC-16729-0288-38.jpg?v=1723548837"},{"product_id":"prolia-denosumab-60-mg-ml-prefilled-syringe-injection-by-amgen-rx","title":"Prolia Denosumab 60 mg\/mL Prefilled Syringe Injection by Amgen (RX) **Requires Refrigeration**","description":"\u003cp\u003eProlia® (denosumab) is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.\u003c\/p\u003e\n\u003cp\u003eProlia (denosumab) 60 mg\/mL is a prescription medication manufactured by Amgen, available in a prefilled syringe for subcutaneous injection. This biologic agent is primarily used to treat osteoporosis in postmenopausal women and men at high risk for fractures. It works by inhibiting a specific protein involved in bone resorption, ultimately improving bone density and reducing the likelihood of fractures.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Denosumab\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e  60 mg\/mL per prefilled syringe\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdministration: Subcutaneous injection, typically administered once every six months\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand:\u003c\/strong\u003e Prolia®\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer\u003c\/strong\u003e: Amgen Inc\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eApplication:\u003c\/strong\u003e Bone Resorption Inhibitor\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContainer Type: \u003c\/strong\u003ePrefilled Syringe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e Injection\u003c\/li\u003e\n\u003cli\u003ePreservative Free\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC Number\u003c\/strong\u003e: 55513-0710-01\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUPC: \u003c\/strong\u003e355513710015\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage Requirements\u003c\/strong\u003e: Requires Refrigeration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTreatment of osteoporosis in postmenopausal women at high risk for fracture.\u003c\/li\u003e\n\u003cli\u003eIncrease in bone mass in men with osteoporosis at high risk for fracture.\u003c\/li\u003e\n\u003cli\u003eTreatment of bone loss in men receiving androgen deprivation therapy for prostate cancer.\u003c\/li\u003e\n\u003cli\u003eTreatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDenosumab is a monoclonal antibody that targets and binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand), a protein essential for the formation, function, and survival of osteoclasts (cells responsible for bone resorption). By inhibiting RANKL, Prolia effectively decreases the breakdown of bone, leading to increased bone mass and strength.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration Instructions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdministered by a healthcare professional or with proper training for self-administration\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eInjection site should be the upper arm, upper thigh, or abdomen\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFollow proper sterilization techniques to minimize the risk of infection\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects may include back pain, musculoskeletal pain, elevated cholesterol levels, and urinary tract infections. Serious adverse reactions could involve hypocalcemia (low blood calcium levels), serious infections, dermatologic reactions, and osteonecrosis of the jaw.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStore in a refrigerator between 2°C to 8°C (36°F to 46°F)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDo not freeze\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eProtect from light\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eKeep the syringe in the outer carton until ready for use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eContraindications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eHypersensitivity to denosumab or any inactive ingredient in Prolia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePatients with hypocalcemia must have their condition corrected before receiving Prolia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEnsure adequate intake of calcium and vitamin D to mitigate the risk of hypocalcemia\u003c\/li\u003e\n\u003cli\u003eRegular monitoring of calcium levels, especially in individuals at risk\u003c\/li\u003e\n\u003cli\u003eInform your healthcare provider of any medical conditions, including existing dental problems or upcoming dental procedures\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProlia represents an important advancement in the management of osteoporosis and other related conditions, offering a significant improvement in patient outcomes through its targeted approach to bone preservation.\u003cbr\u003e\u003c\/p\u003e","brand":"Amgen","offers":[{"title":"Default Title","offer_id":40388475682888,"sku":"55513-0710-01","price":2450.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Prolia-Denosumab-60-mg_mL-Prefilled-Syringe-Injection-by-Amgen.jpg?v=1725886109"},{"product_id":"xgeva-denosumab-injection-vial-120-mg-1-7-ml-70-mg-ml-single-dose-vial-by-amgen-rx","title":"Xgeva Denosumab Injection Vial 120 mg\/1.7 mL (70 mg\/mL) Single-Dose Vial by Amgen (RX) ** Requires Refrigeration","description":"\u003cp\u003eXgeva® is a prescription medication containing the active ingredient denosumab. It is supplied in a single-dose vial, delivering 120 mg of denosumab in a 1.7 mL solution (70 mg\/mL). Xgeva® is manufactured and distributed by Amgen, a leader in biotechnology.\u003c\/p\u003e\n\u003cp\u003eDenosumab works by inhibiting the RANK ligand (RANKL), a protein essential for the formation, function, and survival of osteoclasts, the cells that break down bone. By inhibiting RANKL, Xgeva® helps to reduce bone resorption and maintain bone strength, thus preventing fractures and other bone-related complications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eXgeva® is primarily used to prevent skeletal-related events in patients with bone metastases from solid tumors. It is also used for the treatment of giant cell tumor of bone that is unresectable or when surgical resection is likely to result in severe morbidity. Additionally, Xgeva® is indicated for the treatment of hypercalcemia of malignancy that is refractory to bisphosphonate therapy.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration and Dosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eXgeva® is administered via subcutaneous injection. The recommended dosage for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePrevention of skeletal-related events in patients with bone metastases from solid tumors: 120 mg once every 4 weeks.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eTreatment of giant cell tumor of bone: 120 mg once every 4 weeks, with additional 120 mg doses on days 8 and 15 of the first month of therapy.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eTreatment of hypercalcemia of malignancy: 120 mg once every 4 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eStorage and Handling:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStore Xgeva® in a refrigerator at 2°C to 8°C (36°F to 46°F) in its original carton to protect from light.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDo not freeze.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDo not shake the vial.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePrior to administration, Xgeva® may be kept at room temperature (up to 25°C or 77°F) for a maximum of 14 days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects include fatigue, weakness, hypophosphatemia, nausea, and diarrhea. Serious potential side effects include osteonecrosis of the jaw, atypical femoral fractures, and severe symptomatic hypocalcemia, particularly in patients with risk factors such as reduced renal function.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings and Precautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMonitor calcium levels prior to and during treatment.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eEnsure sufficient intake of calcium and vitamin D.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with pre-existing hypocalcemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRegular dental check-ups and good oral hygiene are recommended to reduce the risk of osteonecrosis of the jaw.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePatient Counseling Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePatients should be informed about the purpose of the treatment, potential side effects, and the importance of maintaining regular check-ups. They should be advised to report any symptoms of hypocalcemia (e.g., muscle spasms, cramps, tingling) and to practice good oral hygiene to reduce the risk of jaw problems. \u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eXgeva® is a critical treatment option for managing bone complications associated with cancer and certain bone tumors. Proper administration and patient adherence to guidelines are essential for maximizing the therapeutic benefits and minimizing risks.\u003c\/p\u003e","brand":"Amgen","offers":[{"title":"Default Title","offer_id":40388499603528,"sku":"55513-0730-01","price":4495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Xgeva-Denosumab-Injection-Vial-120-mg.jpg?v=1725888233"},{"product_id":"zoledronic-acid-injection-4-mg-5-ml-0-8-mg-ml-single-dose-viial-5-ml-by-avet-pharmaceuticals-rx","title":"Zoledronic Acid Injection 4 mg\/ 5 mL (0.8 mg\/mL) Single-Dose Viial 5 mL (RX)","description":"\u003cp\u003eZoledronic Acid Injection is used to treat various bone-related conditions. It is commonly prescribed to manage osteoporosis in postmenopausal women and men, reducing the risk of fractures. It also treats Paget's disease of bone and lowers high blood calcium levels (hypercalcemia) associated with cancer. As a bisphosphonate, zoledronic acid works by inhibiting bone resorption, thus strengthening bones and decreasing bone pain. It is typically administered intravenously by healthcare professionals, ensuring appropriate dosage and patient monitoring.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSpecifications: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e: Zoledronic Acid\u003cbr\u003e\u003cstrong\u003eConcentration\u003c\/strong\u003e: 0.8 mg\/mL\u003cbr\u003e\u003cstrong\u003eVolume:\u003c\/strong\u003e 5 mL per vial\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vial\u003cbr\u003e\u003cstrong\u003eBrand:\u003c\/strong\u003e Avet Pharmaceuticals\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003eIntravenous injection\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration and Formulation:\u003c\/strong\u003e Each vial contains 4 mg of zoledronic acid in a 5 mL solution (0.8 mg\/mL).\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vial provides exact dosage for individual treatments.\u003cbr\u003e\u003cstrong\u003eApplications:\u003c\/strong\u003e Effective in treating osteoporosis, Paget's disease of bone, and managing hypercalcemia due to cancer.\u003cbr\u003e\u003cstrong\u003eQuality and Efficacy:\u003c\/strong\u003e Known for its therapeutic reliability, manufactured under strict quality control criteria.\u003cbr\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Designed for intravenous infusion under the supervision of a qualified healthcare provider.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eZoledronic acid is a bisphosphonate, a class of drugs that inhibit osteoclast-mediated bone resorption. By binding to bone mineral, zoledronic acid disrupts the osteoclast activity, leading to decreased bone breakdown and turnover. The net effect is an increase in bone mineral density, reducing the risk of fractures in osteoporosis and slowing the progression of bone damage in other related conditions. Additionally, by lowering serum calcium levels, it effectively treats hypercalcemia associated with malignancy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Preparation:\u003c\/strong\u003e Ensure that the patient is well-hydrated before administering the drug to minimize the risk of renal adverse effects.\u003cbr\u003e\u003cstrong\u003e2. Dosage and Administration:\u003c\/strong\u003e Administer as an intravenous infusion over no less than 15 minutes. Follow specific dosing instructions based on the condition being treated and the patient's health status.\u003cbr\u003e\u003cstrong\u003e3. Monitoring:\u003c\/strong\u003e Regularly check renal function and serum calcium levels pre-and post-administration to ensure patient safety and drug efficacy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Cautions:\u003c\/strong\u003e Use with caution in patients with compromised renal function. Dose adjustment may be necessary.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypocalcemia:\u003c\/strong\u003e Ensure proper calcium and vitamin D supplementation prior to administration to reduce the risk of hypocalcemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity Reactions:\u003c\/strong\u003e Discontinue immediately if signs of allergic reactions or severe skin reactions occur.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Lactation:\u003c\/strong\u003e Not recommended for pregnant or lactating women unless clearly needed and prescribed by a healthcare professional.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile the medication is generally well-tolerated, some patients may experience side effects, including:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Fever, fatigue, musculoskeletal pain, and flu-like symptoms.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious Side Effects: \u003c\/strong\u003eRenal impairment, acute phase reactions, hypocalcemia, and in rare cases, osteonecrosis of the jaw.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring Required:\u003c\/strong\u003e Close observation for any adverse effects, particularly in individuals with pre-existing conditions that affect renal or bone health.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eZoledronic Acid Injection 4 mg\/5 mL by [Manufacturer Name] represents a crucial intervention for managing bone-catastrophic conditions, ensuring that patients receive informed, safe, and effective treatment aimed at preserving bone integrity and overall physical health. Always consult and adhere to healthcare professional guidance when administering this medication.\u003c\/p\u003e","brand":"Avet Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40388509368392,"sku":"23155-0170-31","price":43.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Zoledronic-Acid-Injection-4-mg-by-Avet-Pharmaceuticals_038bd6a0-5d1d-4f67-a402-cd13e35395cc.jpg?v=1731424616"},{"product_id":"prednisone-tablets-2-5-mg-by-endo-usa-100-count-rx","title":"Prednisone Tablets 2.5 mg by Endo USA 100 Count (RX)","description":"\u003cp\u003ePrednisone Tablets 2.5 mg are used to treat various inflammatory and autoimmune conditions by suppressing the immune system. They are effective in managing allergic reactions, asthma, rheumatoid arthritis, lupus, and skin disorders. Prednisone helps reduce inflammation, pain, and swelling, providing relief from symptoms. It is also used in certain cancer treatments and to prevent organ rejection in transplants. The dosage and duration depend on the specific condition and patient response, and it is typically used under strict medical supervision.\u003c\/p\u003e\n\u003cp\u003ePrednisone Tablets 2.5 mg by Endo Pharmaceuticals is a highly effective corticosteroid designed to manage a variety of inflammatory and autoimmune conditions. Whether for acute or chronic treatment, these tablets provide relief by reducing inflammation and modulating immune response, making them indispensable in the therapeutic arsenal for conditions such as arthritis, allergies, asthma, and certain skin disorders. Packaged in a convenient 100-count bottle, Prednisone by Endo assures both value and quality for consistent patient care.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage Strength:\u003c\/strong\u003e Each tablet contains 2.5 mg of prednisone.\u003cbr\u003e\u003cstrong\u003eCount: \u003c\/strong\u003e100 tablets per bottle, ensuring an adequate supply for extended treatment courses.\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Endo Pharmaceuticals, known for delivering high-quality and reliable pharmaceutical products.\u003cbr\u003e\u003cstrong\u003eIndications: \u003c\/strong\u003eUsed for managing inflammatory and autoimmune diseases including rheumatoid arthritis, lupus, asthma, allergies, multiple sclerosis, and as an adjunctive therapy in certain cancer treatments.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePrednisone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by inhibiting leukocyte infiltration at the site of inflammation, interfering with mediators of inflammatory response, and suppressing humoral immune responses. It achieves this by altering the transcription of inflammatory and immune-related genes, leading to a decrease in the production of pro-inflammatory cytokines and chemical mediators.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe prescribed dosage varies widely based on the medical condition, patient response, and corresponding medical protocols. Typically, the healthcare provider sets the exact daily or alternate day regimen tailored to the individual needs of the patient.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdminister orally with a full glass of water, preferably with food or milk to minimize gastrointestinal upset.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGradual dosage adjustment is recommended under professional supervision to prevent withdrawal symptoms in long-term usage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProlonged use may lead to steroid-related side effects such as adrenal suppression; hence abrupt discontinuation should be avoided.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePatients with systemic fungal infections should not use prednisone; contraindicated for individuals with known hypersensitivity to the drug.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eUse with caution in individuals with conditions such as diabetes, hypertension, osteoporosis, and peptic ulcer disease.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMay mask signs of infection and lead to new infections due to immune system suppression.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePregnant or nursing women should only use prednisone if clearly needed and under professional guidance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eWhile prednisone effectively reduces inflammation, it may produce side effects, particularly with long-term use, including:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Increased appetite, weight gain, insomnia, mood swings, acne, dry skin, increased sweating.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious:\u003c\/strong\u003e Hypertension, high blood sugar levels, Cushing's syndrome, increased risk of infections, osteoporosis, adrenal insufficiency upon withdrawal, peptic ulcers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePrednisone Tablets 2.5 mg by Endo provides a robust solution for managing a spectrum of inflammatory and autoimmune disorders. Its proven efficacy in reducing inflammation and modulating immune responses contributes significantly to patient management in both acute and chronic settings. As with all steroids, judicious use is essential to minimize side effects and optimize therapeutic outcomes, under the vigilant guidance of a healthcare professional.\u003c\/p\u003e","brand":"Endo","offers":[{"title":"Default Title","offer_id":51707168489840,"sku":"00603-5336-21","price":11.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Prednisone-Tablets-2.5-mg-by-Endo_c757a786-1e5e-4676-8909-5c09336b577f.jpg?v=1748455221"},{"product_id":"cyclophosphamide-for-injection-500-mg","title":"Cyclophosphamide Injection 500 mg Single-Dose Vial (RX)","description":"\u003ch1\u003eCyclophosphamide Injection 500 mg – Alkylating Chemotherapy\/Immunosuppressant\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eCyclophosphamide\u003c\/strong\u003e is a potent alkylating agent (nitrogen mustard derivative) used in oncology and severe autoimmune diseases. The 500 mg injection is supplied as a sterile lyophilized powder (200 mg\/mL concentrate when reconstituted). It is a \u003cstrong\u003eprodrug\u003c\/strong\u003e that requires activation in the liver: cytochrome P450 enzymes convert cyclophosphamide to active metabolites (primarily 4-hydroxycyclophosphamide\/aldophosphamide), which then degrade to \u003cstrong\u003ephosphoramide mustard\u003c\/strong\u003e (the DNA-alkylating moiety) and acrolein. Phosphoramide mustard forms covalent intra- and inter-strand DNA crosslinks (especially at guanine N7) that block DNA replication and transcription, triggering tumor cell apoptosis. Acrolein is a toxic byproduct responsible for the drug’s urotoxicity (hemorrhagic cystitis) \u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eUses and Indications\u003c\/h2\u003e\n\u003cp\u003eCyclophosphamide injection is indicated for various \u003cstrong\u003emalignancies\u003c\/strong\u003e as part of combination chemotherapy regimens. It is active against many hematologic and solid tumors, including Hodgkin and non-Hodgkin lymphomas, multiple myeloma, chronic and acute leukemias, neuroblastoma, breast carcinoma, ovarian adenocarcinoma, retinoblastoma and others. Typical adult dosing (when used alone) is 40–50 mg\/kg IV over 2–5 days, or 10–15 mg\/kg IV every 1–2 weeks, or 3–5 mg\/kg IV twice weekly (total dose varies by protocol). In practice, cyclophosphamide is rarely given as monotherapy; more often it appears in regimens like CHOP (with doxorubicin, vincristine, prednisone), BEP (with bleomycin, etoposide), or as a conditioning agent before bone marrow transplant.\u003c\/p\u003e\n\u003ch2\u003eOff-label uses:\u003c\/h2\u003e\n\u003cp\u003eCyclophosphamide’s immunosuppressive effect (lymphocyte depletion) makes it useful in severe autoimmune disorders. Intravenous cyclophosphamide pulses are used in refractory rheumatoid arthritis, systemic lupus erythematosus (especially lupus nephritis), vasculitides (Wegener’s, microscopic polyangiitis), multiple sclerosis, and other steroid-resistant inflammatory diseases. (These indications are NOT on the FDA label and require careful risk–benefit assessment.) In rheumatology, typical pulse dosing might be 500–1000 mg IV monthly.\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eFormulation:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eThe 500 mg vial contains cyclophosphamide monohydrate powder. Reconstitute per label: add sterile water for injection to the vial (e.g. 2.5 mL to yield 200 mg\/mL). Then further dilute in IV fluid to at most 2 mg\/mL (e.g. add to 250–500 mL compatible diluent). Suitable diluents include 5% dextrose or 0.9% saline. The prepared solution is light yellow and should be inspected for particulates; any sign of “melting” or particulate matter requires discarding the vial. Cyclophosphamide is a \u003cstrong\u003ehazardous drug\u003c\/strong\u003e (cytotoxic). Follow safety protocols when handling – wear gloves, eye protection, and gown; use a chemoprotected syringe\/needle, and dispose of sharps properly. Many facilities use a biological safety cabinet for compounding.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eAdministration and Nursing Technique\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute and timing:\u003c\/strong\u003e Cyclophosphamide \u003cstrong\u003emust be given IV only\u003c\/strong\u003e (never IM or subcutaneous), after dilution. There is \u003cstrong\u003eno intrathecal use\u003c\/strong\u003e – accidental intrathecal administration is fatal. Give by slow infusion: infuse 500 mg (2.5 mL reconstituted to 200 mg\/mL) over 15–30 minutes, or longer at high doses, to avoid hypotension and toxicity. (Some protocols call for infusing 1000 mg or more over 2 hours in transplant prep.) It is often given \u003cstrong\u003ein the morning\u003c\/strong\u003e to allow forced diuresis during waking hours.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHydration:\u003c\/strong\u003e Aggressive IV hydration is critical to reduce bladder toxicity. Ensure the patient drinks or receives IV fluids so that urine output remains brisk. In practice, patients are kept on continuous IV fluids (e.g. D5W or saline) during and for 24 hours after infusion. Encourage frequent voiding.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAdjunctive Mesna (prevent hemorrhagic cystitis):\u003c\/strong\u003e For high-dose regimens (cumulative cyclophosphamide ≥ 60 mg\/kg, or single doses \u0026gt;1–2 g\/m^2), prophylactic \u003cstrong\u003emesna\u003c\/strong\u003e is often used. Mesna binds acrolein in the urine, preventing bladder irritation. The label notes that mesna \u003cem\u003e“has been used to prevent severe bladder toxicity”\u003c\/em\u003e. Typical mesna dosing is 20–60% of the cyclophosphamide dose, given IV at the same time and again at 4 and 8 hours.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreparation and labeling:\u003c\/strong\u003e Reconstituted cyclophosphamide (after adding sterile water) has limited stability. Use immediately or store refrigerated (2–8°C) for up to 8 hours. Once diluted in drip fluids, keep the solution cool and use within 24–36 hours (see Prescriber’s label for exact times). Label the infusion clearly as “Cyclophosphamide – Cytotoxic” and date\/time.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMonitoring during infusion:\u003c\/strong\u003e Check IV access patency (avoid extravasation – cyclophosphamide tissue extravasation requires immediate saline washout). Monitor vital signs; hypotension can occur if infused too rapidly. Observe patient for immediate hypersensitivity (rash, bronchospasm) – though true allergic reactions are rare, histamine release and flushing may occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePost-infusion care:\u003c\/strong\u003e Continue IV fluids post-dose for at least 12–24 hours. Encourage oral fluids and frequent voiding for the next day. Provide antiemetics prophylactically (cyclophosphamide causes moderate-to-severe nausea\/vomiting). Common choices are ondansetron or dimenhydrinate given just before and 4–6 hours after the infusion.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects and Precautions\u003c\/h2\u003e\n\u003cp\u003eCyclophosphamide’s toxicity is largely dose-related. Key adverse effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMyelosuppression (bone marrow toxicity):\u003c\/strong\u003e Cyclophosphamide can cause profound leukopenia, neutropenia, thrombocytopenia and anemia. This is dose-limiting – nadir blood counts typically occur 7–14 days post-infusion. \u003cstrong\u003eSevere immunosuppression\u003c\/strong\u003e can lead to life-threatening infections. Monitor CBC with differential \u003cstrong\u003ebefore each cycle\u003c\/strong\u003e and weekly during therapy. Do not give cyclophosphamide if marrow reserves are low (e.g. prior radiation, other chemo). Provide growth factor or transfusions if indicated. Instruct the patient to check temperature daily and report fever or signs of infection immediately.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHemorrhagic cystitis (urinary toxicity):\u003c\/strong\u003e Acrolein metabolite irritates the bladder lining, causing \u003cstrong\u003ehemorrhagic cystitis, urethritis, hematuria\u003c\/strong\u003e. This can be severe or even fatal. Preventive measures are essential: ensure adequate hydration and frequent voiding; administer mesna when indicated; check urine for occult blood after treatment. If hematuria occurs, stop cyclophosphamide and evaluate (possible bladder irrigation or cystoscopy).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal:\u003c\/strong\u003e Nausea and vomiting are common (often within hours of infusion). Use antiemetics prophylactically. Mucosal ulceration (stomatitis, esophagitis) can occur at high doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAlopecia:\u003c\/strong\u003e Hair loss is frequent and often complete; regrowth occurs weeks after stopping therapy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGonadal toxicity (infertility):\u003c\/strong\u003e Cyclophosphamide is highly gonadotoxic. It can cause \u003cstrong\u003eovarian failure and amenorrhea\u003c\/strong\u003e in women and \u003cstrong\u003eazoospermia\u003c\/strong\u003e in men. The risk is higher with larger cumulative doses and older age. Patients should be warned of possible permanent sterility. Discuss fertility preservation (sperm or oocyte banking) before treatment in appropriate patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSecondary malignancies:\u003c\/strong\u003e Cyclophosphamide is a known carcinogen\/genotoxic. Long-term therapy increases risk of new cancers, especially \u003cstrong\u003eurinary bladder carcinoma\u003c\/strong\u003e and hematologic malignancies (acute leukemia, myelodysplasia). (Urinary tract cancers in cyclophosphamide patients are often linked to hemorrhagic cystitis.) Always emphasize bladder protection and use the minimum effective dose.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCardiotoxicity:\u003c\/strong\u003e At very high doses, cyclophosphamide can cause acute cardiac toxicity (myocarditis, pericarditis, heart failure). This is rare at standard regimens, but warrants caution in patients with existing heart disease.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSIADH\/hyponatremia:\u003c\/strong\u003e Rarely, cyclophosphamide can cause severe dilutional hyponatremia (water retention with SIADH-like syndrome). (Ensure patients do not overconsume hypotonic fluids after infusion.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOther:\u003c\/strong\u003e Interstitial pneumonitis\/pulmonary fibrosis (with extended use), skin pigmentation changes, nail changes. Cyclophosphamide can interfere with wound healing (avoid elective surgeries soon after infusion).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eContraindications and Special Considerations\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Contraindicated if patient has known allergy to cyclophosphamide (rare) (\u003ca rel=\"noopener noreferrer\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=14f194db-d4f1-42a7-8d10-d5cfd6465836#:~:text=CONTRAINDICATIONS\" class=\"kZ98Q\" data-underline=\"always\" data-statsig-eventable=\"true\" data-statsig-event=\"api-link-clicked\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUrinary obstruction:\u003c\/strong\u003e Contraindicated in acute bladder outlet obstruction or anuria (\u003ca rel=\"noopener noreferrer\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=14f194db-d4f1-42a7-8d10-d5cfd6465836#:~:text=Hypersensitivity%20to%20cyclophosphamide%20\" class=\"kZ98Q\" data-underline=\"always\" data-statsig-eventable=\"true\" data-statsig-event=\"api-link-clicked\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e). Always ensure good renal function and no blockages before giving.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy\/Breastfeeding:\u003c\/strong\u003e Cyclophosphamide is \u003cstrong\u003eteratogenic and abortifacient\u003c\/strong\u003e. Category D – avoid in pregnancy (women of childbearing age must use effective contraception). Use in pregnancy only for life-threatening conditions (e.g. certain cancers, lupus nephritis) and only under specialist care. It is excreted in breast milk, so breastfeeding is contraindicated during treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfertility counseling:\u003c\/strong\u003e (as above) Discuss fertility risks with both men and women prior to therapy (\u003ca rel=\"noopener noreferrer\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=14f194db-d4f1-42a7-8d10-d5cfd6465836#:~:text=Male%20and%20female%20reproductive%20function,\" class=\"kZ98Q\" data-underline=\"always\" data-statsig-eventable=\"true\" data-statsig-event=\"api-link-clicked\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaccinations:\u003c\/strong\u003e Do \u003cstrong\u003enot\u003c\/strong\u003e give live vaccines during or immediately after therapy. Patients are immunocompromised.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e There are no major drug-drug interactions via cytochrome P450 inhibition noted (cyclophosphamide requires activation). However, concurrent use with other marrow-suppressants (e.g. radiation, other cytotoxics) synergistically increases neutropenia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eNursing and Clinical Tips\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreparation:\u003c\/strong\u003e Before use, check the vial for damage or “melted” contents (cyclophosphamide can crystallize or melt if overheated). Add diluent carefully (the powder may foam). Label the solution once prepared. Use designated cytotoxic equipment and double-glove when handling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHydration:\u003c\/strong\u003e Educate the care team to enforce IV fluids and voiding during and after infusion. (Nurse tip: Record intake\/output closely for 24 hours.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAntiemetics:\u003c\/strong\u003e Administer anti-nausea meds (ondansetron, dexamethasone) 30–60 min before infusion to improve patient comfort.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Check vital signs and observe for infusion reactions. Assess urine color and blood periodically. Draw CBC prior to each dose; post-dose, monitor counts weekly until recovery. Check renal function (BUN\/Cr) and liver enzymes periodically.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePatient education:\u003c\/strong\u003e Instruct patients about side effects: hair loss (advise head covering if desired), avoid prolonged sun exposure (photosensitivity). Emphasize reporting any fever, burning on urination, blood in urine, or unexplained bruising immediately. Reinforce strict birth control and postponing pregnancy. Advise them that immune defenses will be low – avoid crowds\/sick contacts.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHandling spills\/exposure:\u003c\/strong\u003e As a hazardous agent, any spill must be cleaned up per facility protocol (chemotherapy spill kit). If skin contact occurs, wash thoroughly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCyclophosphamide injection is a cornerstone of many treatment protocols due to its broad cytotoxic activity. However, it requires careful dosing, vigorous prevention of bladder toxicity, and close monitoring of blood counts and organ function. By following proper infusion techniques and citing the guidelines above, clinicians can maximize its therapeutic benefits while minimizing risks.\u003c\/p\u003e\n\u003ch2\u003eProduct Details and Features\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Name: \u003c\/strong\u003eCyclophosphamide for Injection\u003cbr\u003e\u003cstrong\u003eStrength: \u003c\/strong\u003e500 mg per single-dose vial\u003cbr\u003e\u003cstrong\u003eManufacturer: \u003c\/strong\u003eLong Grove\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003eSterile powder for reconstitution and intravenous or intramuscular administration\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e Secure and sterile packaging to preserve potency and integrity until reconstitution\u003cbr\u003e\u003cstrong\u003eIndications: \u003c\/strong\u003ePrimarily indicated for the treatment of malignant lymphomas, multiple myeloma, leukemia, mycosis fungoides, neuroblastoma, ovarian carcinoma, and breast carcinoma. Also used in conditioning regimens prior to bone marrow transplantation and in certain autoimmune disorders.\u003cbr\u003e\u003cstrong\u003eStorage Conditions:\u003c\/strong\u003e Store vials at controlled room temperature, 20°C to 25°C (68°F to 77°F). Protect from light.\u003c\/p\u003e\n\u003ch2\u003eFeatures\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad-spectrum Usage:\u003c\/strong\u003e Effective against a variety of cancer types and suitable for autoimmune conditions.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Clinical Efficacy:\u003c\/strong\u003e Well-documented results in oncology as a monotherapy or in combination regimens.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReliable Manufacturing: \u003c\/strong\u003eProduced by Long Grove, guaranteeing quality assurance in every vial.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDirections for Use\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. Reconstitution: \u003c\/strong\u003eAseptically reconstitute the 500 mg powder with an appropriate volume of Sterile Water for Injection (as indicated in product literature) to ensure complete dissolution.\u003cbr\u003e\u003cstrong\u003e2. Administration: \u003c\/strong\u003eAdminister intravenously over a specified period or intramuscularly, taking care to consider the therapeutic regimen that may require dose adjustments based on patient tolerance and intended outcomes.\u003cbr\u003e\u003cstrong\u003e3. Dosage: \u003c\/strong\u003eDosage is highly individualized according to type and stage of cancer, patient size, and regimen (monotherapy or combination therapy). Medical professionals should establish protocols.\u003cbr\u003e\u003cstrong\u003e4. Supervision: \u003c\/strong\u003eTherapy should be administered under the superintendency of a qualified medical professional experienced in cancer chemotherapy.\u003c\/p\u003e\n\u003ch2\u003eWarnings\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression: \u003c\/strong\u003eMonitor blood counts frequently as cyclophosphamide can induce leukopenia, thrombocytopenia, and anemia.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSecondary Malignancies:\u003c\/strong\u003e Long-term use may risk developing secondary malignancies.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eToxicity:\u003c\/strong\u003e Risks include cardiotoxicity at high dosages, potential liver toxicity.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity Reactions:\u003c\/strong\u003e Some patients may demonstrate hypersensitivity leading to adverse reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eWhile cyclophosphamide is often tolerated given its therapeutic importance, it may cause side effects:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Nausea, vomiting, alopecia, and fatigue.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious: \u003c\/strong\u003eHemorrhagic cystitis due to acrolein (a metabolite); requires adequate hydration and possibly mesna therapy for prevention.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmunosuppressive Effects:\u003c\/strong\u003e Increased risk of infection due to bone marrow suppression.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal and Dermatological: \u003c\/strong\u003eMucosal damage and skin reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCyclophosphamide for Injection is a critical component in cancer therapy, with proven effectiveness across diverse malignancies. Always consult with healthcare professionals for suitability, dosage, and monitoring to optimize therapeutic outcomes while minimizing adverse effects. Trust Cyclophosphamide by Long Grove to be a cornerstone of effective oncological care.\u003c\/p\u003e","brand":"Long Grove Pharmaceuticals","offers":[{"title":"Default Title","offer_id":51833236291952,"sku":"81298-8110-01","price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cyclophosphamide-Injection-500-mg-Long-Grove-Pharmaceuticals-81298-8110-01.jpg?v=1764791716"},{"product_id":"paclitaxel-injection-6-mg-multiple-dose-onco-tain-glass-fliptop-vial-5-ml-rx","title":"Paclitaxel Injection 6 mg Multiple Dose Onco-Tain Glass Flip-top Vial 5 mL (RX)","description":"\u003cp\u003eDiscover the benefits of Paclitaxel Injection for cancer treatment. Explore its role in chemotherapy and oncology care for better health.\u003c\/p\u003e\n\u003cp\u003ePaclitaxel Injection 6 mg multiple-dose vial is a chemotherapy medication used to treat various types of cancer, including breast, ovarian, lung, and AIDS-related Kaposi's sarcoma. It works by inhibiting cell division, effectively slowing or stopping the growth of cancer cells. This medication is typically administered in a healthcare setting under professional supervision. Side effects may include nausea, hair loss, and potential low blood cell counts. Patients should be monitored for allergic reactions and heart rate changes during treatment.\u003c\/p\u003e\n\u003cp\u003ePaclitaxel Injection 6 mg\/mL is a pivotal chemotherapy agent formulated by Pfizer Injectables, designed to combat various malignancies. Packaged in a 5 mL Multi-Dose Onco-Tain Glass Fliptop Vial, this product offers both efficacy and convenience. As a cornerstone in oncologic treatment regimens, Paclitaxel works meticulously to inhibit cancer cell proliferation, making it invaluable in the therapeutic arsenal against cancer. The Onco-Tain vial design ensures the stability and sterility of this vital medication, catering to the demanding requirements of medical professionals and patients alike.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Paclitaxel 6 mg\/mL\u003cbr\u003e\u003cstrong\u003eDosage \u003c\/strong\u003eForm: Injection\u003cbr\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e 5 mL Multi-Dose Onco-Tain Glass Fliptop Vial\u003cbr\u003e\u003cstrong\u003eManufacturer: \u003c\/strong\u003ePfizer Injectables\u003cbr\u003e\u003cstrong\u003eStabilized Formulation:\u003c\/strong\u003e Ensures prolonged efficacy\u003cbr\u003e\u003cstrong\u003eSecure Packaging:\u003c\/strong\u003e Designed to maintain sterility and drug integrity\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePaclitaxel functions primarily by disrupting the normal function of microtubule growth and stabilization in cell division. By promoting microtubule assembly and inhibiting their disassembly, Paclitaxel effectively halts mitosis, thereby preventing cancer cells from dividing. This disruption causes cell cycle arrest at the G2\/M phase, leading to apoptosis, or programmed cell death, in rapidly proliferating cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Administration:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePaclitaxel Injection should be administered under the supervision of a qualified oncologist experienced in chemotherapy administration.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eIntravenous administration is required, following proper dilution with an appropriate solution as recommended.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e2. Dosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe dosage is determined based on the individual patient’s body surface area, type of cancer, and specific therapy regimen.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e3. Preparation and Precautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUse protective equipment when handling the vial. \u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe solution must be inspected visually for particulate matter and discoloration prior to administration. \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity: \u003c\/strong\u003eSevere hypersensitivity reactions have been reported; appropriate premedication is necessary.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Marrow Suppression:\u003c\/strong\u003e Monitor blood cell counts regularly; neutropenia is a significant risk.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUse in Pregnancy: \u003c\/strong\u003ePregnant women should not use Paclitaxel due to potential harm to the fetus.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLiver Function:\u003c\/strong\u003e Monitor liver function regularly, as impaired liver function can increase toxicity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExtravasation: \u003c\/strong\u003eEnsure proper drug administration to avoid tissue damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAlopecia (hair loss)\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea and vomiting\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMucositis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePeripheral neuropathy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnaphylaxis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSevere neutropenia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eCardiovascular issues, including hypotension\u003c\/li\u003e\n\u003cli\u003eSevere hypersensitivity reactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients and caregivers need to maintain vigilant monitoring for side effects during treatment, with prompt communication with healthcare providers to manage and mitigate adverse reactions.\u003c\/p\u003e\n\u003cp\u003eIn summary, Paclitaxel Injection by Pfizer Injectables is an essential chemotherapy agent known for its potent action against cancer cells. Its reliable formulation and stringent safety measures provide a transformative approach to cancer treatment, albeit with necessary precautions based on its potent pharmacologic profile.\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":51853219561840,"sku":"61703-0342-09","price":18.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Paclitaxel-Injection-6-mg-by-Pfizer-Injectables.jpg?v=1739193956"},{"product_id":"fulvestrant-injection-prefilled-syringes-50-mg-per-5-ml-2-pack","title":"Fulvestrant Injection Prefilled Syringes 50 mg per 5 mL (2-Pack)","description":"\u003cp\u003eFulvestrant, marketed under the brand name Faslodex, is an injectable hormonal therapy used to treat hormone receptor-positive (HR+) breast cancer in postmenopausal women. It works by blocking and breaking down estrogen receptors on cancer cells, helping to slow or halt the growth of tumors that depend on estrogen. Fulvestrant Injection Prefilled Syringes are used to treat certain types of hormone receptor-positive breast cancer in postmenopausal women. Fulvestrant is an estrogen receptor antagonist that works by blocking and degrading estrogen receptors, which slows the growth of cancer cells that require estrogen to grow. It is often used in patients for whom other treatments have not been effective.\u003c\/p\u003e\n\u003cp\u003eIntroducing Fulvestrant Injection Prefilled Syringes by Amneal Pharmaceuticals—an advanced treatment option for hormone receptor-positive metastatic breast cancer. Each prefilled syringe of 50 mg per 5 mL delivers precision and ease, designed to optimize therapeutic outcomes in targeted cancer therapy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat It Is Used For:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFulvestrant is used to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTreat hormone receptor-positive metastatic breast cancer in postmenopausal women\u003c\/li\u003e\n\u003cli\u003eServe as either first-line therapy or after other hormonal therapies have failed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe standard regimen is 500 mg administered intramuscularly on days 1, 15, and 29, followed by 500 mg every month thereafter. Dosage adjustments are made based on specific patient needs and medical guidance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCDC Guidelines:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWhile the CDC does not provide specific guidance for Fulvestrant, it emphasizes the importance of evidence-based cancer treatments. Follow oncologist recommendations for safe and effective use.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 50 mg per 5 mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 2 prefilled syringes per pack\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Amneal Pharmaceuticals\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality:\u003c\/strong\u003e High-grade formulation ensuring consistency\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenience:\u003c\/strong\u003e Ready-to-use prefilled syringes for precise dosing\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReliability:\u003c\/strong\u003e Trusted in oncology care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFulvestrant is an estrogen receptor antagonist that works by binding to estrogen receptors and accelerating receptor degradation, thereby blocking the growth-promoting effects of estrogen on cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdminister intramuscularly by a healthcare professional.\u003c\/li\u003e\n\u003cli\u003eEnsure adherence to the dosing schedule for optimal results.\u003c\/li\u003e\n\u003cli\u003eRotate injection sites to reduce discomfort.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUse with caution in patients with bleeding disorders or liver impairment.\u003c\/li\u003e\n\u003cli\u003eNot recommended for use in pregnant or breastfeeding women.\u003c\/li\u003e\n\u003cli\u003eInform your healthcare provider of all concurrent medications and health conditions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInjection site pain\u003c\/li\u003e\n\u003cli\u003eHot flashes\u003c\/li\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSeek medical attention if you experience:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSigns of an allergic reaction (rash, difficulty breathing)\u003c\/li\u003e\n\u003cli\u003eSwelling or severe pain at the injection site\u003c\/li\u003e\n\u003cli\u003eUnusual bleeding or bruising\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFulvestrant Injection Prefilled Syringes by Amneal Pharmaceuticals offers a streamlined approach to managing hormone receptor-positive metastatic breast cancer. Utilize under the guidance of a healthcare professional for maximum safety and efficacy.\u003c\/p\u003e","brand":"Amneal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":52236098371952,"sku":"70121-1463-02","price":289.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Fulvestrant-Prefilled-Syringes-50-mg-per-mL.jpg?v=1746197690"},{"product_id":"eribulin-mesylate-injection-1-mg-2-ml-0-5-mg-ml","title":"Eribulin Mesylate Injection 1 mg\/2 mL (0.5 mg\/mL) Single-Dose Vial 2 mL (RX)","description":"\u003cp\u003e\u003cstrong\u003eEribulin Mesylate Injection 1 mg\/2 mL (0.5 mg\/mL)\u003c\/strong\u003e is an FDA-approved, cutting-edge antineoplastic agent used in the treatment of \u003cstrong\u003emetastatic breast cancer\u003c\/strong\u003e and \u003cstrong\u003eunresectable or metastatic liposarcoma\u003c\/strong\u003e. This single-dose, sterile, 2 mL vial delivers precise dosing and reliable administration in hospital, infusion center, and oncology clinic settings. Eribulin Mesylate is a synthetic analog of halichondrin B, proven to extend survival in patients with advanced or treatment-resistant cancer.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eAdvanced Chemotherapy for Metastatic Breast Cancer \u0026amp; Liposarcoma\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003cstrong\u003eUses:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eEribulin Mesylate Injection is indicated for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetastatic Breast Cancer:\u003c\/strong\u003e In patients who have previously received at least two chemotherapy regimens for late-stage disease, including an anthracycline and a taxane (unless contraindicated).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnresectable or Metastatic Liposarcoma:\u003c\/strong\u003e In adults who have received prior anthracycline-containing chemotherapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFor Intravenous Infusion Only\u003c\/strong\u003e: Not for intramuscular, subcutaneous, or oral administration. Must be diluted and administered under healthcare professional supervision.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eEribulin is a \u003cstrong\u003emicrotubule dynamics inhibitor\u003c\/strong\u003e—it blocks cancer cell growth and division, helping reduce tumor size and slow cancer progression. As a non-taxane microtubule inhibitor, it offers an alternative for patients resistant to conventional chemotherapy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeutropenia (low white cell count)\/leukopenia:\u003c\/strong\u003e Risk of infection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnemia, thrombocytopenia:\u003c\/strong\u003e Fatigue or bruising\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeripheral Neuropathy:\u003c\/strong\u003e Tingling, numbness, or pain in hands and feet\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHair loss (alopecia), constipation, nausea, vomiting\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFatigue, fever, muscle pain (myalgia)\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eSevere neutropenia or febrile neutropenia (potentially life-threatening infections)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eQT interval prolongation and heart rhythm disturbances\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLiver dysfunction and increased liver enzymes\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSevere allergic\/anaphylactic reactions\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e Regular monitoring of blood cell counts, liver function, and heart (ECG) is required during therapy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eContraindications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eHypersensitivity to Eribulin or components\u003c\/li\u003e\n\u003cli\u003ePregnancy and breastfeeding (Category D: may cause fetal harm)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eCDC and Chemotherapy Safety Guidelines:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAccording to CDC and OSHA guidelines for chemotherapy agents:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEribulin Mesylate Injection must be administered \u003cstrong\u003eonly by trained healthcare providers\u003c\/strong\u003e, in certified facilities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrict adherence to cytotoxic drug handling\u003c\/strong\u003e (PPE, negative pressure rooms, closed-system drug-transfer devices).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDouble-check dosage \u0026amp; patient identity\u003c\/strong\u003e before administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDispose of used vials and materials as hazardous medical waste\u003c\/strong\u003e in accordance with federal and local regulations.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePregnant or breastfeeding staff should not prepare or handle eribulin injections.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eMonitor patients for infusion reactions and cytopenias per protocol.\u003c\/li\u003e\n\u003cli\u003eProvide \u003cstrong\u003epre-treatment and ongoing patient education\u003c\/strong\u003e for symptom and infection reporting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eAlways consult institutional protocols and CDC Safe Handling of Hazardous Drugs for full safety guidance.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWhy Choose Eribulin Mesylate Injection?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinically proven\u003c\/strong\u003e to prolong overall survival in advanced cancer\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUniform dosing:\u003c\/strong\u003e 1 mg\/2 mL single-dose vial simplifies preparation\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile, ready-to-use packaging\u003c\/strong\u003e for oncology pharmacy safety\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOptimized for hospital, infusion center, and oncology clinic protocols\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSupported by NCCN, ASCO, ESMO, and CDC guidelines\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eEribulin Mesylate Injection 1 mg\/2 mL (0.5 mg\/mL): Advanced, Targeted Cancer Care\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOrder today\u003c\/strong\u003e for hospital and oncology pharmacy use—empower your fight against advanced breast cancer and liposarcoma with the most trusted, safety-optimized injectable chemotherapy!\u003c\/p\u003e","brand":"Hikma Injectables","offers":[{"title":"Default Title","offer_id":52657741922672,"sku":"00143-9167-01","price":775.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Eribulin-Mesylate-Injection-1-mg_2-mL-Hikma.jpg?v=1762262191"},{"product_id":"fulvestrant-injection-250-mg-per-5-ml-50-mg-per-ml-single-dose-prefilled-syringe-2-syringe-kit","title":"Fulvestrant Injection 250 mg per 5 mL, 50 mg per mL Single-Dose Prefilled Syringe (2 Syringe Kit)","description":"\u003ch1\u003eFulvestrant Injection 250 mg\/5 mL (50 mg\/mL) – Prefilled Syringe\u003c\/h1\u003e\n\u003cp\u003eFulvestrant (brand: Faslodex) is a \u003cstrong\u003eselective estrogen receptor downregulator (SERD)\u003c\/strong\u003e used in postmenopausal women with advanced or metastatic hormone receptor–positive (ER+) breast cancer. It binds estrogen receptors and accelerates their degradation, acting as a pure antiestrogen (no agonist effects). By downregulating ER, fulvestrant deprives ER+ tumor cells of estrogen-driven growth.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e Fulvestrant injection is indicated for postmenopausal women with \u003cstrong\u003eHR+ (ER+), HER2-negative advanced or metastatic breast cancer\u003c\/strong\u003e. It can be used as monotherapy in women who are endocrine therapy–naïve or whose disease has progressed on prior hormonal therapy. It is also approved in combination with CDK4\/6 inhibitors (ribociclib, palbociclib, or abemaciclib) for first-line or subsequent endocrine-based therapy in this population.\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eDosage and Administration:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eThe standard dose is \u003cstrong\u003e500 mg\u003c\/strong\u003e intramuscularly (IM) on Days 1, 15, 29, and then once every 28 days (monthly). Each 500 mg dose is given as \u003cstrong\u003etwo 5 mL injections\u003c\/strong\u003e (250 mg per syringe); typically one injection is given in each buttock (gluteal muscle) to allow administration of the full 5 mL volume safely. Each injection should be administered \u003cstrong\u003edeep IM\u003c\/strong\u003e over 1–2 minutes to minimize local irritation. (The solution is a viscous oil-based formulation, requiring slow injection.) For patients with moderate hepatic impairment (Child-Pugh B), the dose is reduced to \u003cstrong\u003e250 mg\u003c\/strong\u003e IM on the same schedule (one 5 mL injection). No dose adjustment is needed for renal impairment. Fulvestrant is for \u003cstrong\u003ehealthcare provider use only\u003c\/strong\u003e (injection); patients do not self-administer. If therapy is repeated after disease recurrence, the same schedule may be used as before.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eAdverse Reactions:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCommon side effects (≥5% of patients) include injection site pain, nausea, bone pain, arthralgia (joint pain), headache, back pain, fatigue, pain in extremities, hot flashes, vomiting, loss of appetite, asthenia (weakness), musculoskeletal pain, cough, difficulty breathing, and constipation. Injection-site reactions (pain, swelling, erythema) are common due to the oil-based solution; patients should be monitored for local reactions. Elevated liver enzymes (ALT, AST, alkaline phosphatase) occurred in \u0026gt;15% of patients so periodic liver function tests are recommended. Rare but serious effects include allergic reactions (anaphylaxis, rash), severe injection-site reactions (including risk of sciatic nerve injury with improper gluteal injection), and interstitial lung disease (very rare). Because fulvestrant is an antiestrogen, it can cause osteoporosis over the long term, so bone density should be monitored in susceptible patients.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\n\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eWarnings and Precautions\u003c\/strong\u003e\u003c\/span\u003e:\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eBefore each dose, assess for injection complications. Use \u003cstrong\u003ecaution in patients with coagulopathies or on anticoagulants\u003c\/strong\u003e, as IM injections may cause bleeding or hematoma. Avoid intravascular injection. Fulvestrant is contraindicated in patients with known hypersensitivity to it or its excipients. It is \u003cstrong\u003eteratogenic\u003c\/strong\u003e: fulvestrant causes fetal harm in animal studies, so it must not be used during pregnancy. Women of childbearing potential should have a negative pregnancy test before starting therapy and use effective contraception during treatment and for one year after the last dose. Advise against breastfeeding during treatment. Because of its estrogen-blocking effect, fulvestrant is not effective in non–hormone-responsive cancers.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eDrug Interactions:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eNo clinically significant drug interactions have been identified. Fulvestrant is metabolized by CYP3A4 in vitro, but coadministration of ketoconazole (inhibitor) or rifampin (inducer) did not produce clinically meaningful changes in fulvestrant levels. Fulvestrant does not inhibit major CYP enzymes, and studies show no significant interactions when used with palbociclib, ribociclib, or abemaciclib. It can be used concurrently with other medications without dose adjustment.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eFormulation and Handling:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eFulvestrant injection is supplied as a clear, colorless to yellow viscous solution in prefilled syringes. Each carton contains two glass syringes (Type I) of 5 mL each (250 mg per syringe), 50 mg\/mL concentration. Store the syringes refrigerated at 2–8°C (36–46°F), protected from light, in the original carton until use. Do not freeze. Remove only before injection. Allow the syringe to reach room temperature before use to ease injection.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003ePatient Counseling:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eInform patients that fulvestrant is given by a healthcare professional via monthly intramuscular injection. Emphasize the importance of attending all injection appointments. Advise patients to report any injection site problems (e.g. severe pain, swelling, numbness) immediately. Explain that some side effects (hot flashes, fatigue, nausea) can occur and to notify their physician if severe. Instruct women to avoid pregnancy and to notify the provider if menstruation resumes (indicative of potential pregnancy).\u003c\/span\u003e\u003c\/p\u003e","brand":"Avenacy","offers":[{"title":"Default Title","offer_id":53788551512432,"sku":"83634-203-74","price":269.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Fulvestrant-Injection-250-mg--Syringes-by-Avenacy.jpg?v=1779115777"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/breast_cancer_treatment_medications.jpg?v=1526558588","url":"https:\/\/www.mountainside-medical.com\/collections\/breast-cancer-treatment-medications.oembed?constraint=acute-asthma","provider":"Mountainside Medical","version":"1.0","type":"link"}